PCN48 IMPACT ON HOSPITAL OUTPATIENT VISIT COSTS BY INITIATING PALONOSETRON VERSUS OTHER 5-HYDROXYTRYPTAMINE3 RECEPTOR ANTAGONISTS FOR PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) AMONG PATIENTS WITH CANCER (English)
- New search for: Craver, C.
- New search for: Gayle, J.
- New search for: Balu, S.
- New search for: Buchner, D.
- New search for: Craver, C.
- New search for: Gayle, J.
- New search for: Balu, S.
- New search for: Buchner, D.
In:
VALUE IN HEALTH
;
14
, 3
;
A163
;
2011
-
ISSN:
- Article (Journal) / Print
-
Title:PCN48 IMPACT ON HOSPITAL OUTPATIENT VISIT COSTS BY INITIATING PALONOSETRON VERSUS OTHER 5-HYDROXYTRYPTAMINE3 RECEPTOR ANTAGONISTS FOR PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) AMONG PATIENTS WITH CANCER
-
Contributors:
-
Published in:VALUE IN HEALTH ; 14, 3 ; A163
-
Publisher:
- New search for: Blackwell Publishing Ltd
-
Publication date:2011-01-01
-
Size:A163
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 610
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 610 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 14, Issue 3
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- A1
-
CO1 COMPARATIVE EFFECTIVENESS ANALYSIS OF TNF BLOCKERS IN RHEUMATOID ARTHRITIS (RA) PATIENTS IN A REAL-WORLD SETTINGBonafede, R. P. / Pearson, D. / Babich, J. / Chastek, B. / Becker, L. / Watson, C. / Chaudhari, S. / Harrison, D. J. / Gandra, S. R. et al. | 2011
- A4
-
SB3 INNOVATIVE DESIGN FOR A COMPARATIVE EFFECTIVENESS STUDY OF SCHIZOPHRENIA TREATMENTS: ANALYSIS OF RECORD REVIEW DATA INCORPORATING RANDOMIZATION AND PROPENSITY SCORE MATCHINGMcCarrier, K. P. / Durkin, M. B. / Dirani, R. / Markowitz, M. / Slabaugh, S. L. / Martin, M. L. et al. | 2011
- A5
-
CE4 USING DYNAMIC TRANSMISSION MODELS TO ESTIMATE THE COST EFFECTIVENESS OF VACCINES: FOUR DIFFERENT METHODS AND THEIR RELEVANCE FOR DECISION MAKERSMauskopf, J. / Talbird, S. E. / Standaert, B. et al. | 2011
- A8
-
MC3 IMPACT OF MULTIPLE MEDICATION COMPLIANCE ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE II DIABETES AND COMORBID HYPERTENSION CONTROLLING FOR ENDOGENEITY BIASAn, J. J. / Nichol, M. B. et al. | 2011
- A9
-
EE4 BOOTSTRAPPING USED TO PROVIDE ROBUST MEAN AND VARIANCE ESTIMATES FOR COMPARING PATIENTS TREATED WITH LIRAGLUTIDE TO A LARGE COMPARISON COHORTMcAdam Marx, C. / Ye, X. / Bouchard, J. / Aagren, M. / Conner, C. / Brixner, D. et al. | 2011
- A10
-
MD1 USING COST-EFFECTIVENESS INFORMATION TO ALLOCATE MEDICARE RESOURCES – HOW MUCH MORE HEALTH FOR THE MONEY?Chambers, J. D. / Cohen, J. T. / Neumann, P. J. / Lord, J. / Buxton, M. et al. | 2011
- A12
-
PHP4 WHEN STAKEHOLDERS DON'T AGREE: DISCREPANCIES IN MAB “APPROVALS” OVER THE PAST TEN YEARSMiller, K. L. / Stevens, C. A. et al. | 2011
- A13
-
PHP10 THE TEMPORAL ASSOCIATION BETWEEN PRESCRIBED OPIOIDS AND THE NATIONAL DEATH RATE DUE TO OPIOID POISONINGGokhale, M. N. / Martin, B. et al. | 2011
- A14
-
PHP16 ANALYZING THE EUROPEAN EXTERNAL REFERENCE PRICING SYSTEM USING SPECTRAL GRAPH THEORYLindgren, P. / kerborg, x. et al. | 2011
- A15
-
PHP23 THE IMPACT OF MEDICARE PART D ON PRESCRIPTION VOLUME AND OUT-OF-POCKET COSTS OF MEDICALLY NECESSARY DRUGSSepulveda, B. / Doyle, J. / White, C. et al. | 2011
- A16
-
PHP28 COMPLIANCE WITH TREATMENT GUIDELINE RECOMMENDATIONS: USE OF OVER-THE-COUNTER MEDICATIONS IN PATIENTS RECEIVING BISPHOSPHONATES, ANTIEPILEPTICS, OR CHRONIC OPIOIDSBarnes, K. D. / Heaton, P. C. et al. | 2011
- A17
-
PHP35 DECISION MAKING IN BRAZIL BASED ON HEALTH TECHNOLOGY ASSESSMENT: THE GOOD, THE BAD, AND THE FUTUREMachado, M. / Fonseca, E. / Fonseca, M. et al. | 2011
- A18
-
PHP41 THE CHANGING LANDSCAPE OF ORPHAN DRUG PROVISION IN THE EU5 AND THE UNITED STATESMcConkey, D. et al. | 2011
- A20
-
PHP52 INCREASE IN UNINTENTIONAL FATAL POISONINGS BY NOXIOUS SUBSTANCES IN KANSAS CITY, MISSOURI, FROM 1999 TO 2008Liu, Y. / Cai, J. / Hong, L. / Hoff, G. L. / Okah, F. A. et al. | 2011
- A21
-
PHP59 THE AVAILABILITY AND SIGNIFICANCE OF COST-EFFECTIVENESS DATA FOR INFORMING DECISIONS TO ADD NEW DRUGS TO THE NATIONAL LIST OF HEALTH SERVICES IN ISRAELGreenberg, D. / Wacht, O. / Siebzehner, M. I. et al. | 2011
- A22
-
PHP64 THE RELATIONSHIP BETWEEN FINANCIAL IMPACT AND THE LIKELIHOOD OF DRUG REIMBURSEMENT IN THE AUSTRALIAN HEALTH CARE SYSTEMMauskopf, J. / Chirila, C. / Masaquel, C. / Boye, K. S. / Bowman, L. / Birt, J. / Grainger, D. et al. | 2011
- A23
-
PHP69 HOW MUCH FOR A QALY IN KOREAKim, Y. / Shin, S. / Park, S. / Song, H. / Park, J. / Bae, E. / Ahn, J. et al. | 2011
- A24
-
PHP74 CLINICAL TRIAL LEARNING CURVES AFFECT OUTCOMES MEASUREMENT, PATIENT SAFETY AND TRIAL SUCCESS: CONTRIBUTING FACTORS AND A POTENTIAL SOLUTION IN CLINICAL TRIAL SIMULATIONSpinner, D. S. / Walter, J. W. / Vazquez-Gragg, M. / Bloise, T. / Stafford-Smith, M. / Faulkner, E. C. / Taekman, J. M. et al. | 2011
- A25
-
PHP80 RELATIONSHIP OF HERBAL KNOWLEDGE TOWARDS ATTITUDE FORMATION AMONG FUTURE PHARMACISTSSura, S. D. / Chabria, A. / Sansgiry, S. et al. | 2011
- A26
-
PHP85 APPLYING FUZZY MULTIPLE CRITERIA DECISION MAKING TO ESTABLISH A NEW HEALTH TECHNOLOGY ASSESSMENT SYSTEM WITH COVERAGE IMPLICATIONS IN TAIWAN NATIONAL HEALTH INSURANCELin, C. W. et al. | 2011
- A27
-
PHP90 TRENDS IN UTILIZATION OF PREGNANCY RISK CATEGORY D AND X DRUGS AMONG PREGNANT WOMEN IN THE UNITED STATESShah, A. J. / Patil, D. S. / Kadakia, A. / Aparasu, R. R. et al. | 2011
- A28
-
PHP95 EXPECTED CHANGES IN HEALTH CARE UTILIZATION DUE TO PATIENT PROTECTION AND AFFORDABLE CARE ACTGhushchyan, V. H. / Sullivan, P. W. / Naim, A. / Nair, K. V. et al. | 2011
- A30
-
PHP106 DISPARITY IN ACCESS TO NOVEL DIABETIC AGENTS FOR MEDICARE PART D ELDERLY COMPARED TO COMMERCIAL INSURED PATIENTS: INSIGHT INTO DOWNSTREAM EFFECTS OF CMS FORMULARY COVERAGE GUIDELINES FOR PDP'SSchwartz, E. L. / Davis, E. A. / Belazi, D. / Hasan, S. et al. | 2011
- A31
-
PHP112 DEFINITIONAL CRITERIA FOR CHRONIC FATIGUE SYNDROME: A CRITICAL REVIEWChristley, Y. / Duffy, T. / Martin, C. R. et al. | 2011
- A32
-
PCV3 RISK OF HOSPITALIZATIONS FOR VENOUS THROMBOEMBOLISM IN ATYPICAL VERSUS TYPICAL ANTIPSYCHOTIC USERS IN A NATIONAL SAMPLE OF MEDICARE BENEFICIARIES: A CLAIMS DATA ANALYSISDharmarajan, S. H. / Yang, Y. / Athavale, A. S. / Bentley, J. P. / Null, K. D. / Banahan, B. F. et al. | 2011
- A34
-
PCV15 PREDICTORS OF THE COMBINED DIAGNOSIS HYPERLIPIDEMIA AND HYPERTENSION - A NHANES 2007-2008 STUDYBhounsule, P. / Abughosh, S. et al. | 2011
- A35
-
PCV20 PERSISTENCE WITH STATINS AND PRIMARY PREVENTION OF CARDIOVASCULAR EVENTS: A POPULATION-BASED COHORT STUDYChodick, G. / Shalev, V. / Goldstein, I. / Porath, A. / Simah, V. et al. | 2011
- A37
-
PCV31 ASSOCIATION BETWEEN HEART FAILURE AND IN-HOSPITAL MORTALITY IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTIONPhatak, H. / Pan, X. / Kawabata, H. et al. | 2011
- A38
-
PCV36 EVALUATION OF THE HOSPITAL RESOURCE UTILIZATION ASSOCIATED WITH TOLVAPTAN USAGE AMONG HEART FAILURE PATIENTS WITH HYPONATREMIA FROM THE EVEREST TRIALDasta, J. F. / Chiong, J. R. / Kim, S. / Lin, J. et al. | 2011
- A39
-
PCV42 A DECISION MODELING APPROACH TO EVALUATE THE COST-EFFECTIVENESS OF PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH PLANNED PERCUTANEOUS CORONARY INTERVENTIONRao, S. / Lin, F. J. / Ojo, O. / Patel, V. / Yu, S. / Zhan, L. / Touchette, D. R. et al. | 2011
- A40
-
PCV47 COST-EFFECTIVENESS OF FONDAPARINUX AND ENOXAPARIN IN PATIENTS WITH NON ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME IN BRAZILPepe, C. / Machado, M. / Olimpio, A. / Canella, M. / Ramos, R. et al. | 2011
- A42
-
PCV58 ASSOCIATION BETWEEN HEART FAILURE AND RESOURCE UTILIZATION IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTIONPan, X. / Kawabata, H. / Phatak, H. et al. | 2011
- A43
-
PCV63 THE IMPACT OF CARDIOVASCULAR DISEASE HOSPITALIZATIONS ON CHANGES IN PATIENT ADHERENCE TO ANTIHYPERTENISVE DRUGS IN A MEDICAID POPULATIONYan, X. / Shaya, F. T. et al. | 2011
- A44
-
PCV68 FACTORS ASSOCIATED WITH NON-ADMINISTRATION OF ORDERED PHARMACOLOGIC VENOUS THROMBOEMBOLISM PROPHYLAXIS DOSESShermock, K. M. / Shafir, V. / Streiff, M. B. / Lavallee, D. M. / Pinto, B. L. / Haut, E. / Kraus, P. / Efird, L. / Elder, S. / Rand, C. et al. | 2011
- A45
-
PCV74 ASSESSMENT OF KNOWLEDGE ABOUT HYPERTENSION (HTN) AMONG HYPERTENSIVE PATIENTS IN SOUTHERN PUNJAB, PAKISTANAtif, M. / Asif, M. / Saleem, F. / Ahmad, N. / Saqib, N. et al. | 2011
- A46
-
PCV79 IMPACT OF DISEASE MANAGEMENT PROGRAM “DE TODO CORAZON” OF MUTUAL SER HMO TO CONTROL CARDIOVASCULAR RISK, COHORT 2004-2009, COLOMBIAPaz, J. J. / Granados, C. E. / Morales, C. / Rodriguez, N. / Buitrago, L. A. / Guete, A. / Caceres, H. A. / Ramirez, P. / Pardo, R. et al. | 2011
- A47
-
PCV84 EFFECTIVENESS OF A MEDICAL EDUCATION INTERVENTION TO TREAT HYPERTENSION IN PRIMARY CAREMartinez Valverde, S. / Reyes Morales, H. / Castro Rios, A. / Perez Cuevas, R. / Klunder Klunder, M. / Salinas Escudero, G. et al. | 2011
- A48
-
PCV90 FACTORS ASSOCIATED WITH SELECTIONS OF STATINS AMONG PATIENTS IN A LARGE EMPLOYER-BASED CLAIMS DATABASEZhao, Z. / Peng, X. / Bae, J. P. / Sponseller, C. A. / LeNarz, L. A. et al. | 2011
- A49
-
PCV95 USING COMPUTERIZED PHYSICIAN ORDER ENTRY OF ANTI-HYPERTENSIVE MEDICATIONS TO CONNECT INDICATIONS WITH PRESCRIBING AND IMPROVE PROBLEM LIST DOCUMENTATIONGalanter, W. / Walton, S. / Falck, S. / Rosencranz, H. / Adimadhyam, S. et al. | 2011
- A50
-
PCV100 HEALTH CARE UTILIZATION AND COSTS FOR A MEDICATION THERAPY MANAGEMENT (MTM) PROGRAMPinto, S. L. / Partha, G. et al. | 2011
- A52
-
PCV111 IDENTIFICATION OF RESPONSE SHIFT AMONG HYPERTENSIVE PATIENTS WITH CORONARY ARTERY DISEASE USING TWO STRUCTURAL EQUATION MODELING TECHNIQUESGandhi, P. K. / Ried, L. D. / Huang, I. C. / Kimberlin, C. / Kauf, T. / Suh, D. C. et al. | 2011
- A53
-
PSS4 SYSTEMATIC REVIEW OF THE EPIDEMIOLOGIC LITERATURE ON ATOPIC DERMATITIS IN CHILDRENBerbari, J. / Reynolds, S. / Heil-Ruess, M. / Iskedjian, M. et al. | 2011
- A56
-
PSS20 MEDIATION MODELING AND MEASUREMENT CHARACTERISTICS OF THE ITCH SEVERITY SCORE FROM A PHASE 2B TRIAL OF ORAL CP-690-550 IN PATIENTS WITH MODERATE TO-SEVERE PLAQUE PSORIASISMamolo, C. / Bushmakin, A. G. / Cappelleri, J. C. / Stewart, M. et al. | 2011
- A57
-
PSS25 MEDICATION ADHERENCE TO TOPICAL MEDICATIONS AND HEALTHCARE EXPENDITURES IN MEDICAID-ENROLLED CHILD WITH ATOPIC DERMATITISOu, H. T. / Feldman, S. R. / Balkrishnan, R. et al. | 2011
- A58
-
PSS30 BURDEN OF INFANTILE HEMANGIOMA: DEVELOPMENT OF A QUESTIONNAIRETaieb, C. / Voisard, J. J. / Ruiz, F. et al. | 2011
- A59
-
PSY6 TRANSFUSIONAL IRON OVERLOAD (TIO) MONITORING AND TREATMENT: FINDINGS FROM AN ELECTRONIC MEDICAL RECORDS REVIEW STUDY AT THE MOFFITT CANCER CENTER AND RESEARCH INSTITUTEDuh, M. S. / Wetzstein, G. / Guo, A. / Sasane, M. / Sarda, S. P. / Korves, C. / Wang, S. T. / Wei, R. / Clinton, B. / Ray, L. et al. | 2011
- A60
-
PSY11 BURDEN OF ILLNESS IN FIBROMYALGIA SYNDROME: THE PATIENTS' PERSPECTIVESLee, S. S. / Kim, S. H. / Kim, S. K. / Lee, C. K. / Lee, H. S. / Lee, S. H. / Park, Y. B. / Ko, S. K. / Park, H. J. et al. | 2011
- A61
-
PSY16 PROJECTING THE LIFETIME ECONOMIC COSTS OF OBESITY: A BMI TRAJECTORY-BASED MODELWang, B. C. / Garrison, L. / Alfonso-Cristancho, R. / Wong, E. / Flum, D. / Arterburn, D. / Sullivan, S. D. et al. | 2011
- A62
-
PSY21 COST-EFFECTIVENESS ANALISYS OF TREATMENT WITH AMFEPRAMONE (DIETHYLPROPION) IN OBESITY IN MEXICORamirez Ramirez, M. / Soto-Molina, H. / Rizzoli-Cordoba, A. / Delgado-Ginebra, I. / Pizarro-Castellanos, M. et al. | 2011
- A63
-
PSY26 IMPACT OF HYPONATREMIA ON PATIENT OUTCOMES AND HEALTH CARE RESOURCE UTILIZATION IN HOSPITALIZED PATIENTSDeitelzweig, S. / Amin, A. / Lin, J. / Belk, K. / Baumer, D. / Lowe, T. et al. | 2011
- A64
-
PSY31 HEMOPHILIA A: PATIENT IMPACT AND ECONOMIC BURDEN OF THE DISEASEStrandberg-Larsen, M. / Gater, A. / Thomson, A. et al. | 2011
- A65
-
PSY36 DEVELOPMENT OF THE LUPUS IMPACT TRACKER: A TOOL FOR PATIENTS AND PHYSICIANS TO ASSESS AND MONITOR THE IMPACT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)Jolly, M. / Kosinski, M. / Garris, C. P. / Jhingran, P. M. / Mikolaitis, R. A. / Dennis, G. / Wallace, D. J. / Clarke, A. / Parke, A. / Dooley, M. A. et al. | 2011
- A66
-
PSY42 EPIDEMIOLOGY AND QALITY OF LIFE OF ANEMIC PATIENTS ON DIALYSIS IN RUSSIA: PATIENT-REPORTED DATAVorobyev, P. / Bezmelnitsyna, L. / Borisenko, O. / Eliseeva, E. / Baev, V. / Vezikova, N. et al. | 2011
- A67
-
PSY47 WILLINGNESS TO PAY (WTP) FOR WEIGHT LOSS COACHING: RESULTS FROM THE POWER TRIALAlavi, R. / Appel, L. / Brancati, F. / Clark, J. / Mohr, P. / Daumit, G. et al. | 2011
- A69
-
PSY59 IMPACT OF OBESITY ON AGE-SPECIFIC PREVALENCE OF CHRONIC DISEASES IN THE UNITED STATESPatel, J. G. / Shah, A. / Rajan, S. S. / Aparasu, R. R. / Johnson, M. L. et al. | 2011
- A70
-
PSY64 GE CENTRICITY® ELECTRONIC MEDICAL RECORDS STUDY: COMORBIDITIES AND BIOLOGIC EXPERIENCE AMONG PATIENTS RECEIVING GOLIMUMABTandon, N. / Carter, C. / Haas, S. / Gunnarsson, C. et al. | 2011
- A71
-
PSY70 ASSOCIATION OF PROVIDER CONTINUITY WITH HOSPITALIZATION AMONG FLORIDA MEDICAID ENROLLEES WITH SICKLE CELL DISEASE (SCD)Ma, Q. / Kauf, T. / Hall, A. G. et al. | 2011
- A72
-
PSY75 PREVALENCE RATIOS AGAINST ODDS RATIOS AS EFFECT MEASURES IN A CROSS-SECTIONAL STUDY OF OBESITY AND ITS CHRONIC COMORBID CONDITIONSPatel, J. G. / Rajan, S. S. / Aparasu, R. R. / Johnson, M. et al. | 2011
- A73
-
PSY80 PRIORITIZATION AND WEIGHTING OF PATIENT-RELEVANT ENDPOINTS (PRES) AS PART OF THE IQWIGS EFFICIENCY FRONTIER METHOD IN GERMANYMü / hlbacher, A. / Bridges, J. F. / Bethge, S. / Dintsios, C. M. / Schwalm, A. / Nü / bling, M. et al. | 2011
- A74
-
PUK4 CUMULATIVE EXPOSURE TO NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) AND THE PROGRESSION OF CHRONIC KIDNEY DISEASE (CKD)Yarger, S. / Nwokeji, E. / Trice, S. / Chao, S. / Devine, J. / Potyk, R. / Gutke, G. / Bonnema, A. et al. | 2011
- A76
-
PUK14 A MARKOV MODEL COMPARING SACRAL NEUROMODULATION AND BOTULINUM TOXIN-A FOR MEDICARE PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER REFRACTORY TO CONSERVATIVE CAREGanz, M. / Clemens, J. Q. / Anger, J. / Denevich, S. / Shah, D. / Carlson, A. / Wittek, M. R. / Pashos, C. et al. | 2011
- A77
-
PUK19 KIT73: PRELIMINARY REPORTS OF IMMUNOSUPRESSANT THERAPY PATTERNS IN A COHORT OF POST KIDNEY TRANSPLANT PATIENTS IN BRAZILCarvalho, D. D. / Garcia, V. / Abbud-Filho, M. / Nishikawa, A. M. / Asano, E. / Nita, M. E. / Szabo, S. M. / Levy, A. R. / Carvalho, J. F. / Donato, B. M. et al. | 2011
- A78
-
PUK24 USE OF BIOMARKERS IN PROPENSITY SCORE MATCHING TO MITIGATE CHANNELING BIAS IN A RETROSPECTIVE COHORT OF ESRD PATIENTSWilson, S. M. / Rubin, J. L. et al. | 2011
- A79
-
PMD5 OUTCOME STUDY OF DRUG ELUTING STENT (DES) VERSUS BARE METAL STENT (BMS) IN HONG KONG: A 6-MONTH PILOT STUDYLee, V. / Yan, B. / Chan, T. / Woo, A. / Lee, K. K. / Yu, C. M. et al. | 2011
- A80
-
PMD11 IDENTIFYING POTENTIAL DRIVERS OF COST SAVINGS WITH INSULIN ADMINISTRATION DEVICES IN TYPE-2 DIABETES IN THE UNITED STATESPollock, R. F. / Curtis, B. / Boye, K. S. / Timlin, L. / Valentine, W. J. et al. | 2011
- A81
-
PMD16 COMPARISON OF COST AND CLINICAL OUTCOMES OF OPEN VERSUS LAPAROSCOPIC THORACIC PROCEDURES IN THE UNITED STATESHashemi, L. / Minshall, M. E. et al. | 2011
- A82
-
PMD21 IS CYBERKNIFE A COST-EFFECTIVE OPTION FOR TREATING PROSTATE CANCER?Parthan, A. / Pruttivarasin, N. / Taylor, D. / Davies, D. / Yang, G. / Pawar, V. / Weinstein, M. et al. | 2011
- A85
-
PMD40 METHODOLOGICAL CONSIDERATIONS IN MODELING THE ECONOMIC VALUE OF DIAGNOSTIC ACCURACYFoley, K. / Lim, S. / Schulman, K. L. et al. | 2011
- A86
-
PSU4 SURGEON'S VOLUME-OUTCOMES RELATIONSHIP FOR LOBECTOMIES AND WEDGE RESECTIONS FOR CANCER USING VIDEO-ASSISTED THORACOSCOPIC TECHNIQUESDavid, G. / Gunnarsson, C. / Moore, M. / Howington, J. / Miller, D. / Maddaus, M. / McKenna, R. / Meyers, B. / Swanson, S. et al. | 2011
- A87
-
PSU9 ECONOMIC EVALUATION OF THE CURRENT TREND TOWARDS MORE UNCEMENTED FIXATION IN PRIMARY HIP ARTHROPLASTIES AND THE POTENTIAL IMPACT OF CHANGES OF THE DEVELOPMENT IN ENGLAND AND WALESKontekakis, A. / Gaiser, S. et al. | 2011
- A88
-
PSU14 HEALTH-RELATED QUALITY OF LIFE FOR PATIENTS ON KIDNEY TRANSPLANT WAITING LIST - WHAT FACTORS REALLY MATTER?Ong, S. C. / Chow, W. L. / van der Erf, S. / Joshi, V. D. / Tee, P. S. / Lu, Y. M. / Kee, T. Y. et al. | 2011
- A89
-
PSU20 IS THERE INDICATION BIAS OF RETROSPECTIVE OBSERVATIONAL STUDY?Choi, J. E. / Jang, E. J. / Jung, S. Y. / Lee, E. J. / Lee, N. R. / Joo, C. K. et al. | 2011
- A91
-
PDB6 LONG-TERM EFFECTIVENESS OF MANAGING DIABETES WITH THE CHRONIC CARE MODEL: SIMULATIONS PERFORMED USING ARCHESZgibor, J. C. / Kuo, S. / Schuetz, C. A. / Roberts, M. S. / Cohen, M. D. et al. | 2011
- A92
-
PDB11 COMPARISON OF MULTIVARIABLE-ADJUSTED LOGISTIC REGRESSION WITH PROPENSITY SCORE-MATCHED, PROPENSITY SCORE-STRATIFIED, AND PROPENSITY SCORE-ADJUSTED LOGISTIC REGRESSION MODELSKhoza, S. / Barner, J. C. / Richards, K. et al. | 2011
- A94
-
PDB22 INSULIN GLARGINE PLUS OHAS VERSUS BIPHASIC INSULIN IN TYPE-2 DIABETES – A COST COMPARISONTilling, C. / Owens, D. / Keech, M. et al. | 2011
- A96
-
PDB32 ECONOMIC EVALUATION OF RANIBIZUMAB FOR THE TREATMENT OF DIABETIC MACULAR EDEMA IN CANADAHaig, J. / Lawrence, D. / Barbeau, M. / Blouin, J. / Cruess, A. et al. | 2011
- A97
-
PDB37 MAIL-ORDER PHARMACY USE AND MEDICATION ADHERENCE AMONG MEDICARE PART D BENEFICIARIES WITH DIABETESZhang, L. / Zakharyan, A. / Stockl, K. M. / Harada, A. S. / Curtis, B. S. / Solow, B. K. et al. | 2011
- A98
-
PDB43 TREATMENT COMPLIANCE TO DIABETES CARE: A CROSS-SECTIONAL STUDY FROM PAKISTANParveen, M. / Piyarali, S. et al. | 2011
- A99
-
PDB48 DO WE KNOW WHAT ARE THEY TRADING OFF? – A FEASIBILITY STUDY TO MEASURE QUALITY OF LIFE IN TAIWANESE TYPE-2 DIABETES OUTPATIENTS BY TIME-TRADE-OFF METHODHuang, L. H. / Chen, L. C. / Huang, Y. B. / Hwang, S. J. et al. | 2011
- A100
-
PDB53 PRESCRIBING PATTERN OF ANTIDIABETIC DRUGS IN T2DM PATIENTS TERTIARY CARE HOSPITAL IN INDIARaval, A. D. / Dhanaraj, E. / Bhansali, A. et al. | 2011
- A101
-
PDB58 WHAT IS THE IMPACT OF GENERIC SUBSTITUTION OF ROSIGLITAZONE ON PATIENT OUTCOMES AND TREATMENT COSTS? AN HMO EXPERIENCETriki, N. / Greenberg, D. / Mossinson, D. / Shani, S. et al. | 2011
- A102
-
PDB64 EVALUATION OF THE BURDEN OF ILLNESS OF TYPE-2 DIABETES MELLITUS IN A MEDICARE POPULATIONCostantino, M. E. / Song, F. / Stacy, J. N. / Aagren, M. / Bouchard, J. / Marrett, E. et al. | 2011
- A103
-
PDB69 EXENATIDE (BID) AND LIRAGLUTIDE (QD) TREATMENT PATTERNS AMONG TYPE-2 DIABETES PATIENTS IN GERMANYMiller, L. A. / Burudpakdee, C. / Zagar, A. / Bhosle, M. / Reaney, M. / Schabert, V. F. et al. | 2011
- A105
-
PIH4 COMPARATIVE EFFECTIVENESS OF BANKED DONOR MILK FOR PREMATURE INFANTS: EFFICIENCY OF A MILK BANK MODEL INTEGRATED IN A BLOOD BANK SETTINGRicher, E. / Dourdin, N. / Goetghebeur, M. et al. | 2011
- A106
-
PIH9 COSTS TO THE NATIONAL HEALTH INSURACE SCHEME OF THE FREE MATERNAL HEALTH SERVICE CHALLENGES AND IMPLICATIONS FOR SUSTAINABILITY IN GHANAOdame, E. et al. | 2011
- A108
-
PIH20 ECONOMIC EVALUATION OF THE USE OF EXOGENOUS PULMONARY SURFACTANTS IN PRETERM NEWBORNS WITH RESPIRATORY DISTRESS SYNDROME IN MEXICAN POPULATION COVERED BY THE NEW GENERATION MEDICAL INSURANCESalinas Escudero, G. / Martinez Valverde, S. / Villasis Keever, M. A. / Garduñ / o Espinosa, J. / Reyes Ló / pez, A. / Muñ / oz Herná / ndez, O. et al. | 2011
- A109
-
PIH25 IMPACT OF PATIENT BEHAVIORS AND ATTITUDES ON TERIPARATIDE ADHERENCE IN A MEDICARE PART D POPULATIONFoster, S. / Hazel-Fernandez, L. A. / Uribe, C. / Song, F. / Thomas, N. / Burge, R. T. / Krohn, K. et al. | 2011
- A111
-
PIH37 DUAL VETERAN HEALTH ADMINISTRATION AND MEDICARE USE AND AMBULATORY CARE SENSITIVE HOSPITALIZATIONSAjmera, M. R. / Wilkins, T. L. / Sambamoorthi, U. et al. | 2011
- A112
-
PIH42 A NET BENEFIT FRAMEWORK (NBF) ANALYSIS OF CHART DATA FOR HAEMOPHILIA INHIBITOR PATIENTSWeatherall, J. / Mesterton, J. / Lindgren, P. / Dalen, J. et al. | 2011
- A113
-
PIN1 VACCINE-ASSOCIATED GUILLAIN-BARRE SYNDROME: A PHARMACOVIGILANCE ANALYSIS OF DATA IN THE UNITED STATES' VACCINE ADVERSE EVENT REPORTING SYSTEM (1990-2009)Ali, A. K. et al. | 2011
- A114
-
PIN6 TRENDS OF HEPATITIS A INCIDENCE FROM 2005 TO 2008Eisenberg, D. / Changolkar, A. K. / Misurski, D. A. et al. | 2011
- A116
-
PIN17 TREATMENT PATTERNS AND DRUG TREATMENT COSTS ASSOCIATED WITH NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR (NNRTI)-BASED ANTIRETROVIRAL THERAPY IN TREATMENT-NAÏVE HIV-1 INFECTED PATIENTSDiels, J. / Langham, S. / Nuyts, G. / Adriaenssen, I. et al. | 2011
- A117
-
PIN23 COST-EFFECTIVENESS OF ATAZANAVIR/RITONAVIR (ATV+RTV) COMPARED WITH LOPINAVIR/RITONAVIR (LPV+RTV) IN TREATMENT-NAÏVE HIV-INFECTED PATIENTS IN MEXICO: A MODEL BASED ON THE CASTLE STUDYJuarez-Garcia, A. / Martinez-Rivera, G. / Donato, B. M. et al. | 2011
- A118
-
PIN29 A COST-EFFECTIVENESS ANALYSIS ON THE USE OF DAPTOMYCIN FOR THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS WITH FAILURE TO VANCOMYCIN THERAPY IN MEXICOBriones, B. / Martinez Revelles, M. / Garcí / a-Contreras, F. et al. | 2011
- A119
-
PIN34 INTRANASAL LIVE ATTENUATED (LAIV) VERSUS INJECTABLE INACTIVATED (TIV) INFLUENZA VACCINE FOR CHILDREN AND ADOLESCENTS: A CANADIAN COST EFFECTIVENESS ANALYSISTarride, J. E. / Burke, N. / von Keyserlingk, C. / O'Reilly, D. / Xie, F. / Goeree, R. et al. | 2011
- A120
-
PIN39 IMMUNIZATION BARRIERS AND SUGGESTED SOLUTIONS IN IRAQAl-lela, O. Q. / Bahari, M. B. / Alabbassi, M. G. / Basher, A. Y. et al. | 2011
- A121
-
PIN45 IMPACT OF GOVERNMENT SPONSORED POLIO CONTROL PROGRAM ON KNOWLEDGE, ATTITUDE AND PERCEPTION OF POLIO IN GENERAL COMMUNITY OF BAHAWALPUR, PAKISTANAtif, M. / Asif, M. / Sulaiman, A. / Saleem, F. / Ahmad, N. / Saqib, N. / Qamar, M. et al. | 2011
- A122
-
PIN52 MAPPING STATE AND FEDERAL IMMUNIZATION RECORDS POLICIESHedden, E. / Jessop, A. / Field, R. I. et al. | 2011
- A123
-
PMS4 THE ASSOCIATION BETWEEN TERIPARATIDE PERSISTENCE AND FRACTURE OUTCOMES IN A US CLAIMS DATABASEYu, S. / Foster, S. / Burge, R. / Anderson, J. / Gelwicks, S. / Meadows, E. et al. | 2011
- A124
-
PMS11 APPLYING THE STRATIFIED PROPENSITY SCORE MATCHING METHOD WHEN ESTIMATING HEALTH CARE COSTS OF RHEUMATOID ARTHRITIS PATIENTSBaser, O. / Xie, L. et al. | 2011
- A125
-
PMS16 COST OF RHEUMATOID ARTHRITIS PATIENTS RECEIVING TNF-ANTAGONIST THERAPY FROM THE KOREA NATIONAL HEALTH INSURANCE CLAIMS DATABASEPark, S. J. / Lee, E. K. et al. | 2011
- A126
-
PMS21 ABATACEPT OR INFLIXIMAB FOR RHEUMATOID ARTHRITIS IN VENEZUELA? A COST-EFFECTIVENESS ANALYSISAlfonso-Cristancho, R. / Serra, N. / Aiello, E. C. / Roa, C. N. et al. | 2011
- A127
-
PMS26 COST-EFFECTIVENESS MODELING IN OSTEOPOROSIS: A SYSTEMATIC LITERATURE REVIEW AND OVERVIEWSmolen, H. J. / Myers, J. A. / Smolen, L. J. et al. | 2011
- A128
-
PMS31 TITLE: THE RELATIVE COST-EFFECTIVENESS OF THE MOST COMMON NON-SURGICAL TREATMENTS FOR NECK PAINvan der Velde, G. / Hincapié / C. / Schieir, O. / Coté / P. / Hogg-Johnson, S. / Paulden, M. / Krahn, M. et al. | 2011
- A129
-
PMS37 INDIRECT COMPARISON OF ADALIMUMAB VERSUS ETANERCEPT FOR THE TREATMENT OF PSORIATIC ARTHRITISKirson, N. / Rao, S. / Birnbaum, H. G. / Kantor, E. / Wei, R. / Cifaldi, M. et al. | 2011
- A130
-
PMS42 CONTENT VALIDITY AND HEALTH CARE SYSTEMS: A CASE-STUDYGagol, G. / Fernandez, N. / Rouanet, S. et al. | 2011
- A131
-
PMS47 EMPLOYABILITY-ADJUSTED-LIFE-YEARS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH GOLIMUMAB PLUS METHOTREXATE OR METHOTREXATE ALONEHan, C. / Gathany, T. / Tandon, N. / Hsia, E. et al. | 2011
- A136
-
PRS1 SEVERE ASTHMA EXACERBATIONS ASSOCIATED WITH LONG-ACTING BETA AGONISTS AMONG CHILDREN AND ADOLESCENTS WITH ASTHMAGuo, J. J. / Tsai, K. / Kelton, C. / Bian, B. / Wigle, P. et al. | 2011
- A137
-
PRS6 WATERPIPE SMOKING AMONG JORDANIAN ADULTS: PREDICTORS AND CORRELATESYang, M. / Abughosh, S. / Wu, I. H. / Sansgiry, S. / Peters, R. J. / Hawari, F. I. / Essien, E. J. et al. | 2011
- A138
-
PRS12 A NATIONAL SURVEY OF SOCIETAL COST OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN SOUTH KOREAKim, J. / Park, S. / Kim, Y. / Lee, E. / Oh, Y. / Boo, Y. et al. | 2011
- A139
-
PRS17 COST EFFECTIVENESS OF TOP 20 HIGHEST SELLING DRUGSAggarwal, S. et al. | 2011
- A140
-
PRS22 COPD MAINTENANCE MEDICATION ADHERENCE: INFLUENCE ON HOSPITALIZATION AND SPENDING IN A MEDICARE POPULATIONSimoni-Wastila, L. / Wei, Y. J. / Qian, J. / Zuckerman, I. H. / Stuart, B. / Shaffer, T. / Dalal, A. / Bryant-Comstock, L. et al. | 2011
- A141
-
PRS27 THE DEVELOPMENT OF A PATIENT-REPORTED OUTCOME INSTRUMENT TO EVALUATE NIGHTTIME SYMPTOMS OF COPDPalsgrove, A. / Schaefer, M. / Hareendran, A. / Houghton, K. / Mocarski, M. / Carson, R. / Make, B. et al. | 2011
- A143
-
PRS38 EFFECT OF HAVING A PRESCRIPTION DRUG PLAN ON ASTHMA PATIENTS' USE OF CONTROLLER MEDICATIONSVaidya, V. / Peeters, M. / Partha, G. / Potnis, P. et al. | 2011
- A144
-
PRS43 REGRESSION VERSUS PROPENSITY MATCHING AS OUTCOME ANALYSIS ADJUSTMENT METHODS: EXAMPLE USING COPD INITIAL THERAPIESRoberts, M. / Dalal, A. A. et al. | 2011
- A145
-
PRM2 MEASURING DRUG THERAPY GUIDELINES ON OUTCOMES: A TUTORIALBaser, O. et al. | 2011
- A146
-
PRM8 LEGAL RESTRICTIONS ON THE USE OF QALYS IN PHARMACOECONOMIC ANALYSIS IN GERMANYGissel, C. / Goetz, G. / Repp, H. et al. | 2011
- A147
-
PRM13 COMPARISON OF DISCRETE EVENTS SIMULATION SOFTWARE FOR USE IN HEALTH ECONOMICS & OUTCOMES RESEARCHAnaya, P. et al. | 2011
- A148
-
PRM18 CAN UTILITIES EXCEED 1.0? EMPIRICAL EVIDENCE OF THE CEILING EFFECTSullivan, P. W. / Ghushchyan, V. H. et al. | 2011
- A150
-
PRM29 METHODOLOGICAL DIFFERENCES IN EQ-5D SCORING SYSTEMS: A SYSTEMATIC REVIEW AND ANALYSISPerampaladas, K. / Doble, B. M. / Xie, F. et al. | 2011
- A151
-
PRM35 DEVELOPMENT OF A CONCEPT LIST TO ENSURE COMPARABLE CONTENT VALIDITY BETWEEN ORIGINAL PRO QUESTIONNAIRES AND THEIR TRANSLATIONS: A REVIEW OF 15 YEARS OF LINGUISTIC VALIDATIONSMear, I. / Conway, K. et al. | 2011
- A152
-
PRM40 ISSUES CONCERNING THE TRANSLATION OF THE WORD ‘HASSLED' IN THE MORISKY MEDICATION ADHERENCE SCALE (MMAS-8)Griffin, A. / Wild, D. / Morisky, D. E. et al. | 2011
- A153
-
PRM46 R … YOU AWARE HOW USEFUL IT IS? THE VALUE OF CORRELATION COEFFICIENTS IN META-ANALYSISAl-Dakkak, I. / Patel, S. / Jen, M. H. / von Maltzahn, R. et al. | 2011
- A154
-
PCN2 SAFETY AND TREATMENT PATTERNS OF ANGIOGENESIS INHIBITORS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) IN THE UNITED KINGDOM: PRELIMINARY RESULTS OF AN ONGOING CHARTS REVIEW STUDYHawkins, R. / Wagstaff, J. / Nathan, P. / Sarda, S. P. / Vekeman, F. / Korves, C. / Dasgupta, S. / O'Mara, S. / Fitton, S. / Hayers, J. et al. | 2011
- A156
-
PCN12 RESOURCE UTILIZATION AND PERCEPTIONS OF MAJOR MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA (CML): RESULTS OF A DELPHI PANEL STUDYBollu, V. / Quintas-Cardama, A. / Flamm, M. / Lill, M. / Thirman, M. / Ravandi-Kashani, F. / Akard, L. / Talpaz, M. et al. | 2011
- A158
-
PCN23 IMPACT OF US FOOD AND DRUG ADMINISTRATION'S BLACK BOX WARNINGS ON ADVERSE EVENTS REPORTING RATES FOR MULTIPLE MYELOMA DRUGSGarg, V. / Raisch, D. W. / Mckoy, J. / Trifilio, S. / Holbrook, J. / Samaras, A. T. / West, D. et al. | 2011
- A159
-
PCN28 COST SAVINGS WITH FERRIC CARBOXYMALTOSE THROUGH ITS IMPACT ON ERYTHROPOÏESIS-STIMULATING AGENTS AND BLOOD TRANSFUSION IN CHEMOTHERAPY-INDUCED ANEMIA OF BREAST AND GASTROINTESTINAL CANCER: FRENCH HEALTH CARE PAYER PERSPECTIVELuporsi, E. / Mahi, L. / Moore, C. / Wernli, J. / Bugat, R. et al. | 2011
- A160
-
PCN34 LONG-TERM DIRECT MEDICAL COSTS IN PATIENTS DIAGNOSED WITH FOLLICULAR LYMPHOMA WHO RECEIVE FRONTLINE CHEMOTHERAPY WITH VERSUS WITHOUT RITUXIMAB - A SEER MEDICARE ANALYSISGriffiths, R. I. / Gleeson, M. L. / Mikhael, J. R. / Danese, M. D. et al. | 2011
- A161
-
PCN39 COSTS AT THE END OF LIFE FOR PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER (CRPC)Alemayehu, B. / Parry, D. / Engel-Nitz, N. M. / Kulakodlu, M. / Nathan, F. et al. | 2011
- A162
-
PCN46 HEALTH CARE EXPENDITURES, DISABILITY DAYS, AND RESOURCE UTILIZATION ASSOCIATED WITH CANCER IN EMPLOYER SETTINGS IN THE UNITED STATESTang, D. / Alberts, D. S. / Nevins, R. / Sullivan, S. / Skrepnek, G. H. et al. | 2011
- A164
-
PCN58 IS CYP2D6 GENETIC TEST IN COMBINATION WITH HORMONE THERAPY FOR ER+ HORMONE SENSITIVE WOMEN WITH EARLY BREAST CANCER COST-EFFECTIVE?Djalalov, S. / Beca, J. / Hoch, J. et al. | 2011
- A166
-
PCN68 AN ECONOMIC EVALUATION OF DASATINIB FOR THE TREATMENT OF IMATINIB REISTANT PATIENTS WITH CHRONIC MYELOGENOUS LEUKAEMIATaylor, M. / Lewis, L. / Lebmeier, M. / Wang, Q. et al. | 2011
- A167
-
PCN73 UTILISATION OF ANTINEOPLASTIC AGENTS IN SLOVAK REPUBLICGatialova, K. / Bellova, K. / Petrova, L. / Majtas, J. / Binder, R. et al. | 2011
- A168
-
PCN79 IMPACT OF NON-ADHERENCE TO IMATINIB ON PROGRESSION-FREE SURVIVAL AS 1ST TREATMENT FOR CHRONIC MYELOID LEUKEMIA IN BRAZIL: TWO YEARS FOLLOW UPFunke, V. A. / Moellmann-Coelho, A. / Asano, E. / Nita, M. E. / Donato, B. M. / Rahal, E. et al. | 2011
- A169
-
PCN84 PATIENTS' PREFERENCES FOR THE TREATMENT OF COLORECTAL CANCER: A DISCRETE CHOICE EXPERIMENT (DCE) SURVEYAlbassam, A. / Noyce, P. / Ashcroft, D. et al. | 2011
- A170
-
PCN89 HTA AGENCIES' PREFERENCES REGARDING QUALITY OF LIFE MEASURES FOR PROSTATE CANCER CLINICAL TRIALSPeeters, P. / Casamayor, M. / Moï / se, P. / Holmstrom, S. et al. | 2011
- A172
-
PCN101 HEALTH CARE RESOURCE UTILIZATION AND ECONOMIC BURDEN OF METASTATIC AND RECURRENT LOCALLY-ADVANCED HEAD AND NECK CANCER PATIENTSLe, T. K. / Winfree, K. B. / Yang, H. / Marynchenko, M. / Yu, A. P. / Frois, C. / Wu, E. Q. et al. | 2011
- A173
-
PCN106 RESEARCH ON THE FACTORS AFFECTING THE ADOPTION OF HIGH VALUE MEDICAL CONSUMES IN LESS DEVELOPED AREAS OF CHINAJing, W. / Guanglian, X. et al. | 2011
- A175
-
PCN117 ASSOCIATION OF HEALTH-RELATED QUALITY OF LIFE (HRQOL) WITH ISS STAGE AND ECOG STATUS IN MULTIPLE MYELOMAPashos, C. L. / Durie, B. G. / Mehta, J. / Toomey, K. / Terebelo, H. R. / Abonour, R. / Fonseca, R. / Gasparetto, C. / Narang, M. / Rifkin, R. M. et al. | 2011
- A176
-
PCN121 ONCOLOGY MEDICATION UTILIZATION BASED ON FEDERAL DRUG ADMINISTRATION (FDA) LABELING, NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) CLINICAL PRACTICE GUIDELINE (GL) RECOMMENDATIONS, AND EVIDENCE FOR PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER (NSCLC): AN ANALYSIS FROM THE NCCN ONCOLOGY OUTCOMES DATABASELepisto, E. M. / Vandergrift, J. L. / Kalemkerian, G. P. / Pisters, K. M. / Zornosa, C. / Rabin, M. S. / Reid, M. E. / Koczywas, M. / Otterson, G. A. / Ettinger, D. S. et al. | 2011
- A177
-
PCN126 OVERVIEW OF PRIMARY ENDPOINTS, PROGRESSION-FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) FOR NON-SMALL CELL LUNG CANCER (NSCLC): THEIR VALUE IN TREATMENT DECISIONS AND PATIENT CAREHeron, L. / De Castro Carpeñ / o, J. / Chouaid, C. / Vergnenè / gre, A. / Bischoff, H. G. / Walzer, S. et al. | 2011
- A178
-
PCN131 REPRESENTING UNCERTAINTY IN CALIBRATED CANCER TREATMENT MODELS: A PRACTICAL APPROACHTaylor, D. C. / Leahy, K. J. / Weinstein, M. et al. | 2011
- A179
-
PCN137 COMPREHENSIVE REVIEW OF MANAGEMENT EFFICIENCY STRATEGIES AMONG ONCOLOGY PRACTICES: EXISTING EVIDENCE AND OPPORTUNITIES FOR FUTURE RESEARCHGorman, K. / Miller, R. / McGarvey, N. / Corey-Lisle, P. et al. | 2011
- A180
-
PGI4 PREDICTORS OF HEPATITIS C TREATMENT INITIATIONWagner, J. S. / Goren, A. et al. | 2011
- A181
-
PGI9 COMPARISON OF DIRECT MEDICAL COSTS AND SERVICES BY POINT OF SERVICE AND PRESCRIPTION COST FOR PERSONS WITH HEPATITIS-C WITH AND WITHOUT TREATMENTBrook, R. A. / Kleinman, N. L. / Smeeding, J. et al. | 2011
- A183
-
PGI20 IBS-C PATIENT SYMPTOM REPORTS: ANALYSIS OF EXPLORATORY OPEN-ENDED QUESTIONSCarson, R. T. / Lewis, B. E. / Shiff, S. J. / Johnston, J. M. / Dennee-Sommers, B. / Lasch, K. E. / Hwang, S. / Marquis, P. et al. | 2011
- A185
-
PMH3 RISK OF HIP FRACTURES IN ELDERLY MEDICARE BENEFICIARIES USING ATYPICAL OR TYPICAL ANTIPSYCHOTICS: A PROPENSITY SCORE ANALYSISDharmarajan, S. H. / Yang, Y. / Athavale, A. S. / Bentley, J. P. / Null, K. D. / Banahan, B. F. et al. | 2011
- A186
-
PMH9 RISK OF DEATH IN DUAL ELIGIBLE NURSING HOME RESIDENTS USING ANTIPSYCHOTIC AGENTSAparasu, R. R. / Mehta, S. / Chen, H. et al. | 2011
- A187
-
PMH14 CLINICAL EFFECTIVENESS ANALYSIS OF NALTREXONE VERSUS ACAMPROSATE AND PLACEBO IN ALCOHOL DEPENDENT PATIENTS TREATED WITH PSYCHOTHERAPYJarosz, J. / Miernik, K. / Wachal, M. / Walczak, J. et al. | 2011
- A188
-
PMH19 THE BUDGET IMPACT ANALYSIS OF NALTREXONE IN THE TREATMENT OF ALCOHOL-DEPENDENT PATIENTS IN POLANDWalczak, J. / Semeniuk, A. / Pacocha, K. / Nogas, G. et al. | 2011
- A189
-
PMH24 COMPARISON OF HEALTH CARE COSTS AND UTILIZATIONS BETWEEN PATIENTS WHO WERE TREATED WITH PHARMACOLOGICAL AND NON-PHARMACOLOGICAL SUBSTANCE MEDICATIONS FOR ALCOHOL DEPENDENCYBaser, O. / Wang, L. / Xie, L. et al. | 2011
- A190
-
PMH29 ESTIMATION OF DIRECT COSTS OF TREATING SCHIZOPHRENIA FOR COMMUNITY-DWELLING UNITED STATES RESIDENTSDesai, P. / Lawson, K. / Barner, J. C. / Rascati, K. L. et al. | 2011
- A191
-
PMH35 COMPARISONS OF MENTAL HEALTH-RELATED MEDICAL CARE UTILIZATION AND COSTS FOLLOWING THE INITIATION OF ORAL VERSUS LONG-ACTING INJECTABLE RISPERIDONE IN PATIENTS WITH SCHIZOPHRENIAPark, H. / Kim, D. N. / Rascati, K. L. et al. | 2011
- A192
-
PMH40 COST-EFFECTIVENESS AND BUDGET IMPACT OF ADJUNCT QUETIAPINE FUMARATE EXTENDED-RELEASE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER WITH AN INADEQUATE RESPONSE TO PREVIOUS THERAPYSvedsater, H. / Locklear, J. / Johal, S. / Stillman, I. O. et al. | 2011
- A193
-
PMH45 MEASURES OF MEDICATION ADHERENCE IN ORAL VERSUS LONG-ACTING RISPERIDONE IN TEXAS MEDICAID PATIENTS WITH SCHIZOPHRENIAKim, D. N. / Park, H. / Rascati, K. L. et al. | 2011
- A194
-
PMH50 A TIME-TRADE-OFF STUDY OF HEALTH-RELATED QUALITY OF LIFE ADVANTAGE OF LONG-ACTING INJECTABLE ANTIPSYCHOTIC TREATMENT FOR SCHIZOPHRENIAOsborne, R. H. / Dalton, A. / Hertel, J. / Schrover, R. / Kingsford Smith, D. et al. | 2011
- A195
-
PMH55 THE BURDEN OF DIAGNOSED DEPRESSION AND SLEEP DIFFICULTIES ON QUALITY OF LIFE, WORK PRODUCTIVITY, AND RESOURCE USEGupta, S. / Goren, A. / Gabriel, S. / Kim, E. / Dupclay, L. et al. | 2011
- A196
-
PMH60 BIPOLAR DISORDER RESULTS IN SIGNIFICANT BURDEN ON CAREGIVERS: ANALYSIS OF DATA FROM A LARGE MULTINATIONAL LONGITUDINAL STUDY (WAVE-BD)Vieta, E. / Figueira, M. L. / Bellivier, F. / Souery, D. / Blasco-Colmenares, E. / Langosch, J. M. / Medina, E. et al. | 2011
- A197
-
PMH65 EFFECT OF PRESCRIPTION MONITORING PROGRAMS (PMP'S) ON OPIOID OVERDOSE ADMISSIONPainter, J. T. et al. | 2011
- A199
-
PMH76 PHARMACIST AND PHARMACY STAFF KNOWLEDGE AND ATTITUDES TOWARDS SUICIDE AND SUICIDE PREVENTION AFTER A NATIONAL VA TRAINING PROGRAMLavigne, J. E. / King, D. A. / Lu, N. / Knox, K. L. / Kemp, J. E. et al. | 2011
- A200
-
PMH81 RELATIONSHIP BETWEEN ADHERENCE TO ANTIDEPRESSANT TREATMENTS AND DEPRESSIVE RELAPSEJung, S. Y. / Shin, S. / Song, H. / Park, J. / Ahn, J. et al. | 2011
- A201
-
PND1 PRESCRIBING PATTERNS OF DRUGS HAVING ANTICHOLINERGIC ACTIVITY IN PATIENTS WITH ALZHEIMER'S DISEASEGala, S. D. / Gupte, K. P. / Wu, W. K. et al. | 2011
- A202
-
PND6 THE IMPACT OF SPECIALTY CARE PROGRAMS ON RELAPSES OF MULTIPLE SCLEROSIS USING ADMINISTRATIVE DATATang, J. / Levin, M. C. / Bailey, J. E. / Faris, R. J. / Hong, S. H. / Chang, C. F. / Wang, J. et al. | 2011
- A203
-
PND11 THE ECONOMIC BURDEN OF OSA IN EACH OF THE METABOLIC SYNDROME COMPONENTS LEVELSGreenberg-Dotan, S. / Yan, X. / Scharf, S. M. / Shaya, F. T. et al. | 2011
- A206
-
PND27 MEDICO-ECONOMIC EVALUATION OF LACOSAMIDE ADJUNCTIVE THERAPY IN THE TREATMENT OF PATIENTS WITH REFRACTORY EPILEPSY IN THE UNITED STATESBenhaddi, H. / Helmers, S. et al. | 2011
- A207
-
PND32 HEALTH RESOURCE UTILIZATION AND COSTS FOR MIGRANEURS IN SCOTLANDBloudek, L. M. / Hansen, R. N. / Liu, L. / Batty, A. J. / Varon, S. F. / Lipton, R. B. / Sullivan, S. D. et al. | 2011
- A208
-
PND38 THE HIDDEN TOLL OF CAREGIVER BURDEN IN MULTIPLE SCLEROSISStewart, M. / Phillips, A. / Edwards, N. / Gupta, S. / Goren, A. et al. | 2011
- A209
-
PND43 THE PATIENTSLIKEME® EPILEPSY COMMUNITY: A UNIQUE INSIGHT INTO THE LIVES OF PATIENTS WITH EPILEPSYde la Loge, C. / Dimova, S. / Massagli, M. / Wicks, P. et al. | 2011
- A210
-
PND48 MEASUREMENT CHARACTERISTICS OF THE SF-36 IN CHRONIC NEUROMUSCULAR DISORDERBanks, P. / Martin, C. R. / Petty, R. et al. | 2011
- A211
-
PND54 RETROSPECTIVE DATABASE ANALYSIS OF FREQUENCY AND COSTS OF RELAPSES AMONG MULTIPLE SCLEROSIS PATIENTSBoklage, S. / Preblick, R. / Yaldo, A. / Golick, M. / Pocoski, J. et al. | 2011
- A212
-
PND59 MEDICATION TREATMENT PATTERNS FOR MULTIPLE SCLEROSIS PATIENTS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEMTakemoto, M. M. / Takemoto, M. L. / Fernandes, R. A. / Duarte, G. G. / Moretti, A. I. / Santos, P. M. / Tolentino, A. C. et al. | 2011
- A213
-
PND64 APPLICATION OF PREDICTIVE MODELING TO CLASSIFY FREQUENT SNORING IDENTIFIED FROM ROUTINE MEDICAL EXAMINATIONS USING THE NHANES DATABASERow, B. et al. | 2011
- A215
-
ISPOR 16th Annual International Meeting Financial Disclosure Information for Research Presentations| 2011
- A223
-
ISPOR 16TH Annual International Meeting Research Abstracts Author Index| 2011
- i
-
Table of Contents| 2011
-
CO4 POTENTIAL COST SAVINGS FROM COMPARATIVE EFFECTIVENESS RESEARCH: LESSONS FROM COURAGE STUDYBonakdar tehrani, A. / Howard, D. et al. | 2011
-
IN2 ASSOCIATION BETWEEN DRUG TOLERABILITY AND ECONOMIC IMPACT FOR PROPHYLAXIS OF INVASIVE FUNGAL INFECTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTGao, X. / Ji, X. / Stephens, J. M. / Schlamm, H. / Tarallo, M. et al. | 2011
-
IN3 COSTS ASSOCIATED WITH HCV AND RELATED COMPLICATIONS IN THE UNITED STATES FROM A MANAGED CARE PAYER'S PERSPECTIVEMcAdam Marx, C. / Hane, C. A. / Biskupiak, J. / Deniz, B. / McGarry, L. / Brixner, D. et al. | 2011
-
EE1 SYSTEMATIC REVIEW OF GUIDELINES FOR HEALTH ECONOMIC EVALUATIONSMelnyk, P. / Wagner, M. / Dourdin, N. / Rindress, D. et al. | 2011
-
EE3 PERFORMANCE OF DIFFERENT COMORBIDITY MEASURES IN PREDICTING HEALTH CARE EXPENDITURE IN PATIENTS WITH DEMENTIAJohnson, M. L. / Mehta, S. / Chitnis, A. S. / Bhowmik, D. / Dwibedi, N. / Kamble, P. et al. | 2011
-
PHP8 PHYSICIAN SHORTAGE IMPACT ON PATIENT RX USE FOR SELECT CHRONIC CONDITIONSDall, T. / Seiders, M. / Price, P. / Chakrabarti, R. / Tal, S. / Kowal, S. / Larson, J. et al. | 2011
-
PHP60 ORPHAN DRUGS FACE TOUGHER SCRUTINY IN SECURING FAVORABLE PRICING AND MARKET ACCESSGrosvenor, A. / Saraf, S. / Jones, K. et al. | 2011
-
PHP61 WIDER CONSULTATION IN HEALTH TECHNOLOGY ASSESSMENT (HTA) DECISIONS: BETTER UNDERSTANDING OR A LOBBYING OPPORTUNITY?Bending, M. W. / Hutton, J. / McGrath, C. et al. | 2011
-
PHP71 IMPACT OF THE MEDICARE PART D COVERAGE GAP ON PRESCRIPTION DRUG UTILIZATION AND MEDICATION ADHERENCENaik, R. / Borrego, M. / Dodd, M. / Raisch, D. / Khan, N. / Bakhireva, L. / Gupchup, G. / Cunico, L. et al. | 2011
-
PHP110 BIOSIMILARS LITERATURE REVIEW: THE CURRENT LANDSCAPE AND IMPLICATIONS OF RECENT HEALTH CARE LEGISLATION FOR THE UNITED STATES MARKETMaiese, B. A. / Lee, E. H. / Toscani, M. T. et al. | 2011
-
PCV45 COST-EFFECTIVENESS OF CYP2C9 AND VKORC1 GENOTYPE-GUIDED WARFARIN ANTICOAGULATION CARE: THE IMPLEMENTATION OF DISCRETE EVENT SIMULATION MODEL ON THE NATURAL HISTORY OF VENOUS THROMBOEMBOLISMTeschemaker, R. / Lawrence, W. / Wutoh, A. K. et al. | 2011
-
PCV73 CONSTRUCT VALIDITY OF HEALTH UTILITIES INDEX (HUI) JAPANESE VERSION: CROSS-SECTIONAL STUDY FOR STROKE IN JAPANNoto, S. / Uemura, T. / Izumi, R. / Moriwaki, K. et al. | 2011
-
PCV75 EFFECT OF ACEI AND ARB ON HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH HYPERTENSION AND DIABETESJohnson, M. L. / Parikh, R. / Rajan, S. S. / Aparasu, R. et al. | 2011
-
PCV92 CHANGES IN THE PREVALENCE, TREATMENT AND CONTROL OF HYPERTENSION IN GERMANY? A CLINICAL-EPIDEMIOLOGICAL EXAMINATION OF 50,000 PRIMARY CARE PATIENTS WITH THE DETECT STUDYLabeit, A. / Klotsche, J. / Pieper, L. / Wehling, M. / Wittchen, H. U. et al. | 2011
-
PCV96 TREND IN THE UTILIZATION OF PHARMACOLOGICAL AND NON-PHARMACOLOGICAL TREATMENT STRATEGIES IN THE MANAGEMENT OF NEWLY DIAGNOSED ATRIAL FIBRILLATION PATIENTS IN THE UNITED STATESKashyap, A. / Li, C. et al. | 2011
-
PCV102 COMPLICATIONS ARISING DURING HOSPITALIZATION FOR HEMORRHAGIC OR ISCHEMIC STROKE: EVIDENCE FROM A LARGE ADMINISTRATIVE DATABASECandrilli, S. D. / Karve, S. J. / Wirth, P. E. et al. | 2011
-
PSS2 DIAGNOSED AND UNDIAGNOSED DRY EYE, SYMPTOM SEVERITY, AND ASSOCIATED FACTORS AMONG MEN AND WOMEN IN THE UNITED STATESSchaumberg, D. A. / Li, J. Z. et al. | 2011
-
PSS15 DEVELOPMENT OF A MULTIATTRIBUTE INSTRUMENT FOR ESTIMATING UTILITIES (PREFERENCE WEIGHTS) IN PEOPLE WITH GLAUCOMA FROM THE NATIONAL EYE INSTITUTE VISUAL FUNCTIONING QUESTIONNAIRE (NEI-VFQ)Kymes, S. / Peters, C. M. / Beusterien, K. / Kotak, S. / Grinspan, J. / Stwalley, D. / Pleil, A. et al. | 2011
-
PSS24 MEDICATION CHOICE AND ASSOCIATED HEALTH CARE OUTCOMES AND COSTS FOR PATIENTS WITH ACNE AND ACNE RELATED CONDITIONS IN THE UNITED STATESPatel, P. / Lin, H. C. / Feldman, S. R. / Fleischer, A. B. / Nahata, M. / Balkrishnan, R. et al. | 2011
-
PSS28 EFFECT OF DIFFERENT RECALL PERIODS ON DRY EYE SYMPTOM RATINGSRuiz, W. M. / Li, J. Z. / Johnson, M. E. et al. | 2011
-
PSY15 COSTS OF CARE FOR PRIVATELY INSURED MALES WITH HEMOPHILIA IN THE UNITED STATES, 2008Guh, S. / Grosse, S. / McAlister, S. / Kessler, C. M. / Soucie, M. et al. | 2011
-
PSY30 A REAL-WORLD EVALUATION OF ADHERENCE AND PERSISTENCE OF WEIGHT-LOSS PHARMACOTHERAPY IN THE UNITED STATES: 2007-2010Charland, S. L. / Agatep, B. C. / Aubert, R. E. / Lazzaro, J. / Stanek, E. J. et al. | 2011
-
PSY46 DISEASE SYMPTOMS, TREATMENT SATISFACTION, AND COPING STRATEGIES IN PATIENTS WITH LUPUSLerstrø / m, K. / Crimmings, M. / Govoni, M. / Nikaï / E. / Merrill, J. / Isenberg, D. et al. | 2011
-
PSY66 BIOLOGIC EXPERIENCE AND DOSING OF GOLIMUMAB PATIENTS IN MANAGED CARECarter, C. / Tandon, N. / Smith, D. et al. | 2011
-
PMD27 COST-MINIMIZATION ANALYSIS OF BIOPSY-BASED RISK STRATIFICATION TOOLS IN INTERMEDIATE AND HIGH RISK PROSTATE CANCER PATIENTS BASED ON RESULTS FROM PHYSICIAN CASE STUDIESZubek, V. B. / Khan, F. / Karvir, H. et al. | 2011
-
PMD31 IMPACT OF GASTRIC ELECTRIC STIMULATION ON HEALTH STATE UTILITIES OF DIABETIC GASTROPARESIS PATIENTS: RESULTS FROM A PROSPECTIVE CLINICAL TRIALSoliman, A. M. / Carlson, A. / Wittek, M. R. et al. | 2011
-
PDB2 EVALUATING ONE-YEAR STABILITY OF THE TOTAL ILLNESS BURDEN INDEXBillimek, J. / Cantrell, R. / Greenfield, S. / Kaplan, S. et al. | 2011
-
PDB8 EFFECTIVENESS AND ADHERENCE WITH FIXED-DOSE COMBINATION (FDC) VERSUS COADMINISTERED DUAL THERAPY (CDT) ANTIHYPERGLYCEMIC REGIMENS: A META-ANALYSISHan, S. / Davies, M. J. / Lento, K. / Radican, L. / Zhang, Q. et al. | 2011
-
PDB18 FACTORS ASSOCIATED WITH ROUTINE PROPER MONITORING OF DIABETES CARE AMONG THE NON-INSTITUTIONALIZED POPULATION IN THE UNITED STATES: A RETROSPECTIVE ANALYSIS OF THE 2007 MEDICAL EXPENDITURE PANEL SURVEY (MEPS)Zhao, Y. / Fonseca, V. / Shi, L. et al. | 2011
-
PDB24 DIRECT HEALTHCARE AND INDIRECT WORKLOSS COSTS ASSOCIATED WITH THE ADDITION OF ROSIGLITAZONE (RSG) VERSUS SITAGLIPTIN (STG) THERAPY TO METFORMIN (MET)Lefebvre, P. / Sarda, S. P. / Laliberté / F. / Ramamurthy, P. / Wei, R. / Arondekar, B. / Menditto, L. / Martin, A. A. / Duh, M. S. et al. | 2011
-
PDB73 A CLAIMS-BASED EMPIRIC APPROACH TO ASSESSING MEDICATION POSSESSION FOR PATIENTS INITIATING THERAPY WITH INSULINSBuysman, E. / Conner, C. / Liu, F. / Aagren, M. / Bouchard, J. et al. | 2011
-
PDB74 BETA-VERIFICATION OF A DIABETES MODELING FRAMEWORK AGAINST PUBLISHED COHORT TRIALSFuriak, N. / Bansal, M. / Gahn, J. C. / Smolen, H. et al. | 2011
-
PIH14 PROJECTING THE POTENTIAL COST-EFFECTIVENESS OF UNIVERSAL ACCESS TO MODERN CONTRACEPTIVES IN UGANDABabigumira, J. B. et al. | 2011
-
PIH15 ECONOMIC EVALUATION OF ANALGESIC MANAGEMENT AFTER TOTAL ABDOMINAL HYSTERECTOMY AT THE SOCIAL SECURITY MEXICAN INSTITUTEContreras, I. / Mould-Quevedo, J. F. / Balderas-Peñ / a, L. M. / Goycochea-Robles, M. V. / Garduñ / o-Espinosa, J. et al. | 2011
-
PIH26 MEDICATION COMPLIANCE AND ITS AFFECTING FACTORS IN CLINICAL TRIALS IN SOUTH KOREAOh, Y. / Lee, E. K. et al. | 2011
-
PIN11 EVALUATION OF COSTS AND INCOME OF AN EXTENDED TREATMENT OF CLINICAL MASTITIS CAUSED BY GRAM-POSITIVE PATHOGENS IN DAIRY COWS IN THE UNITED STATES: THE CASE OF PIRLIMYCINVan Vlaenderen, I. / Poulsen Nautrup, B. / Postorino-Reeves, N. / Gasper, S. et al. | 2011
-
PIN19 COST-BENEFIT ANALYSIS OF POSTPARTUM VACCINATION OF BIRTH MOTHERS WITH INFLUENZA VACCINEDing, Y. / Hay, J. W. / Zangwill, K. M. / Yeh, S. H. et al. | 2011
-
PIN24 COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS WITH PALIVIZUMAB AMONG PRETERM INFANTS COVERED BY MEDICAID IN THE UNITED STATESWeiner, L. B. / Polak, M. J. / Masaquel, A. / Mahadevia, P. J. et al. | 2011
-
PIN32 PHARMACOECONOMIC ANALYSIS OF MARAVIROC IN TREATMENT-EXPERIENCED HIV PATIENTS IN BRAZILMachado, M. / Canella, M. / Franco, E. / Zajdenverg, R. et al. | 2011
-
PIN36 ANTIRETROVIRAL REFILL ADHERENCE IN COMMUNITY HIV SPECIALTY PHARMACIES (HIV-SP) VERSUS NON-SPECIALIZED PHARMACIES (NSP)Cocohoba, J. / Murphy, P. / Pietrandoni, G. / Guglielmo, J. et al. | 2011
-
PRS7 USE OF INHALED TOBRAMYCIN IS ASSOCIATED WITH REDUCED MORTALITY IN PATIENTS WITH CYSTIC FIBROSISSignorovitch, J. / Sawicki, G. S. / Zhang, J. / Latremouille-Viau, D. / Wu, E. Q. / von Wartburg, M. / Lizheng, S. et al. | 2011
-
PRS13 ECONOMIC CONSEQUENSES OF USING TULATHROMYCIN, FLORFENICOL, AND TILMICOSIN FOR TREATMENT OF CATTLE AT HIGH RISK OF DEVELOPING BOVINE RESPIRATORY DISEASE IN UNITED STATES FEEDLOTSPoulsen Nautrup, B. / Van Vlaenderen, I. / Holland, R. E. / Gasper, S. et al. | 2011
-
PRS31 DEVELOPMENT OF A QUESTIONNAIRE ASSESSING THE BURDEN OF PRURITUSTaieb, C. et al. | 2011
-
PRS35 PHARMACY QUALITY INDICATORS USING MISSISSIPPI MEDICAID: TESTING PQA-ENDORSED STARTER SET MEASURES AND 2010 TEST MEASURESThumula, V. / Banahan, B. F. / Bentley, J. P. / West-Strum, D. et al. | 2011
-
PRS39 EFFECT OF BIOMASS SMOKE ON CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN RURAL LOCALITIES OF COLOMBIAAlvis, N. / Paternina, A. / Montes, J. / De la Hoz, F. et al. | 2011
-
PRM25 PSYCHOMETRIC COMPARIBILITY OF SINGLE ITEM AND GRID FORM ADMINISTRATION OF THE SF-36V2™ HEALTH SURVEYSmith, K. J. / Kosinski, M. et al. | 2011
-
PRM26 IMPACT OF A WEB PORTAL TOOL ON DRIVING PATIENT ADHERENCEYing, X. / Khandelwal, N. / Korcheck, R. / Duncan, I. et al. | 2011
-
PRM39 LITERATURE REVIEW OF RANDOMIZED, CONTROLLED STUDIES OF THE IMPACT OF PHARMACISTS' INTERVENTIONS TO IMPROVE PATIENT OUTCOMESKharat, A. A. / Borrego, M. / Raisch, D. W. et al. | 2011
-
PCN31 DIRECT MEDICAL COSTS OF ELDERLY PATIENTS WITH STAGE III COLON CANCER DURING FIRST-LINE VERSUS SECOND-LINE CHEMOTHERAPYYang, H. K. / Bikov, K. / Onukwugha, E. / Mullins, C. D. et al. | 2011
-
PCN64 ECONOMIC EVALUATION OF THREE FORMULATIONS OF LEUPROLIDE ACETATE IN ANDROGEN DEPRIVATION THERAPY FOR ADVANCED PROSTATE CANCER IN BELGIUMWex, J. / Sidhu, M. / Odeyemi, I. / Retsa, P. et al. | 2011
-
PCN74 UTILISATION OF DRUGS INVOLVED IN TREATMENT OF STAGE I AND STAGE II BREAST CANCER IN SLOVAK REPUBLICGatialova, K. / Bellova, K. / Majtas, J. / Foltan, V. / Petrova, L. et al. | 2011
-
PCN78 THE DEVELOPMENT OF A VALUE BASED PRICING INDEX FOR NEW DRUGS IN METASTATIC COLORECTAL CANCERDranitsaris, G. / Truter, I. / Lubbe, M. et al. | 2011
-
PCN114 DEVELOPING A FAMILIAL CANCER RISK ASSESSMENT TOOL FOR USE IN UNDERSERVED COMMUNITIESBhattacharjee, S. / Westman, J. A. / Kelly, K. M. et al. | 2011
-
PCN116 TRANSFERABILITY OF NICE RECOMMENDATIONS FOR PHARMACEUTICAL THERAPIES IN ONCOLOGY TO CENTRAL-EASTERN EUROPEAN COUNTRIESKalo, Z. / Landa, K. / Dolezal, T. / Vokó / Z. et al. | 2011
-
PCN124 CLINICAL AND DEMOGRAPHIC CHARACTERISTICS OF CHRONIC MYELOGENOUS LEUKEMIA PATIENTS TREATED AT PUBLIC ONCOLOGY CLINICS IN SÃO PAULO, BRAZILTakemoto, M. L. / Takemoto, M. M. / Fernandes, R. A. / Tolentino, A. C. / Santos, P. M. et al. | 2011
-
PGI14 PERCEIVED VALUE ASSESSMENT OF ENTECAVIR VERSUS TENOFOVIR IN CHRONIC HEPATITIS BVorobyev, P. / Telegina, I. / Borisenko, O. / Jakouloff, D. et al. | 2011
-
PGI19 HEALTH-RELATED QUALITY OF LIFE IS LOWER FOR PATIENTS WITH DIURNAL AND NOCTURNAL GERD SYMPTOMSGoren, A. / Gupta, S. / Balu, S. / Buchner, D. et al. | 2011
-
PMH17 PREVALENCE OF ANTICHOLINERGIC DRUG PRESCRIBING IN ELDERLY OUTPATIENTS WITH DEMENTIABhattacharya, R. / Chatterjee, S. / Aparasu, R. et al. | 2011
-
PMH43 ECONOMIC IMPACT OF CYP450 PHARMACOGENETIC TESTING ON DEPRESSION TREATMENTSyeda, S. S. / Wu, W. K. et al. | 2011
-
PMH75 PSYCHIATRIC MORBIDITY AND BURNOUT AMONG HOSPITAL PHYSICIANS AND NURSES: ASSOCIATION WITH PERCEIVED JOB-RELATED FACTORSTabolli, S. / di Pietro, C. / Renzi, C. et al. | 2011
-
PND5 ASSESSMENT OF PARKINSON'S DISEAES PROGRESSION RATES BY STAGE OF DISEASEJohnson, S. J. / Kaltenboeck, A. / Diener, M. / Tarrants, M. / Birnbaum, H. et al. | 2011
-
PND8 INCIDENCE RATES OF SUBARACHNOID HEMORRHAGE IN PATIENTS WITH UNRUPTURED ANEURYSM IN SOUTH KOREA FROM 2006-2009Lee, E. J. / Kwon, J. W. / Lee, H. J. / Hyun, M. K. / Hwang, J. S. / Kim, J. / Choi, J. / Lee, N. R. et al. | 2011
-
PND13 BURDEN OF ILLNESS IN THE UNITED STATES FOR PEDIATRIC EPILEPSY PATIENTS WITH PARTIAL ONSET SEIZURES RECEIVING ANTI-EPILEPTIC DRUGSCopher, R. / Angalakuditi, M. et al. | 2011
-
PND22 QUANTIFYING COST OUTCOMES DIFFERENTIATED BY GENDER AND AGE IN THE TREATMENT OF MIGRAINE HEADACHE USING STEP AND STRATIFIED CAREFuriak, N. / Bansal, M. et al. | 2011
-
PND35 CREATION OF A WEB-BASED MULTIPLE SCLEROSIS PATIENT-REPORTED OUTCOMES RESEARCH PROGRAMDeering, K. / Agarwal, S. S. / Rajagopalan, K. / Harshaw, Q. / Shillington, A. C. et al. | 2011
-
PND45 ONE YEAR OF NATALIZUMAB TREATMENT IS ASSOCIATED WITH AN IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE IN MULTIPLE SCLEROSIS PATIENTSStephenson, J. J. / Agarwal, S. S. / Kern, D. M. / Kamat, S. A. et al. | 2011
-
PND60 TESTING A COMPUTERIZED METHOD OF ASSESSING MOVEMENT ACCURACYAllen, D. D. / Ng, M. / Greenwald, C. P. et al. | 2011
-
PND62 MEDICATION POSSESSION RATIO (MPR): A COMPARISON OF TRADITIONAL MPR AND MODIFIED MPR FOR MULTIPLE SCLEROSIS (MS) PATIENTS PRESCRIBED DISEASE MODIFYING DRUGS (DMDS)Dickson, M. / Kozma, C. / Phillips, A. / Meletiche, D. M. et al. | 2011
-
PHP97 PRO LABEL CLAIMS: AN ANALYSIS BASED ON A REVIEW OF PROS AMONG NEW MOLECULAR ENTITIES AND BIOLOGIC LICENSE APPLICATIONS 2006-2010Mordin, M. / Clark, M. / DeMuro, C. / Evans, E. / Copley-Merriman, K. / Fehnel, S. / Gnanasakthy, A. et al. | 2011
-
PHP105 HOW ARE COVERAGE DECISIONS MADE IN PUBLICLY FUNDED HEALTH CARE PROGRAMS IN LOW- AND MIDDLE-INCOME COUNTRIES?Hornberger, J. / Shewade, A. / Gutierrez, H. et al. | 2011
-
PHP111 OVER INFLATION OF THE GENETIC CONTRIBUTION TO SCHIZOPHRENIA: IMPLICATIONS FOR NOVEL THERAPEUTICSFleming, M. / Martin, C. R. et al. | 2011
-
PCV59 PERSISTENCE AND COMPLIANCE IN HYPERTENSIVE PATIENTS TREATED WITH FIXED OR UNFIXED COMBINATIONS OF ANGIOTENSIN RECEPTOR BLOCKERS, AMPLODIPINE AND HYDROCHLOROTHIAZIDESandberg, A. / Kostev, K. / Ehlken, B. / Holz, B. / Oberdiek, A. et al. | 2011
-
PSY35 VALIDATION OF THE LUPUS IMPACT TRACKERJolly, M. / Kosinski, M. / Garris, C. P. / Jhingran, P. M. / Mikolaitis, R. A. / Dennis, G. / Wallace, D. J. / Clarke, A. / Parke, A. / Dooley, M. A. et al. | 2011
-
PCV82 EVALUATION OF RELATIONSHIP BETWEEN BLOOD PRESSURE CONTROL AMONG HYPERTENSIVE PATIENTS AND INTEGRATION OF SERVICES WITHIN PHYSICIAN ORGANIZATIONSSmalarz, A. / Fraser, K. / Wong, K. / Wu, N. / Wogen, J. / Boulanger, L. et al. | 2011
-
PSS6 SAFETY PROFILE OF LATANOPROST VERSUS TIMOLOL IN PATIENTS WITH OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION: POST 2000 SETTINGGupta, J. / Siddiqui, M. K. / Jindal, R. / Sehgal, M. et al. | 2011
-
PSS9 COST-EFFECTIVENESS OF COLLAGENASE VERSUS HYDROGEL DRESSINGS FOR CHRONIC-WOUND DEBRIDEMENT IN A LONG-TERM CARE SETTINGWaycaster, C. et al. | 2011
-
PSY5 AN INVESTIGATION INTO THE RELATIONSHIP BETWEEN OBESITY AND SKIN AND SOFT TISSUE INFECTIONS REQUIRING HOSPITALIZATIONSwiney, J. et al. | 2011
-
PSY17 A PHARMACOECONOMIC EVALUATION OF ROMIPLOSTIM (NPLATE®) FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) IN MEXICOArocho, R. / Northridge, K. / Rivera Hurtado, R. / Garcí / a Chá / vez, J. et al. | 2011
-
PSY23 ECONOMIC EVALUATION OF ERYTHROPOIESIS STIMULATING AGENTS IN CRITICALLY ILL TRAUMA PATIENTSChui, B. K. / Hazel, M. / Dong, J. / Klarenbach, S. et al. | 2011
-
PSY49 PREDICTORS OF OBESITY TREATMENT (COUNSELING OR PHARMACOTHERAPY) IN AMBULATORY SETTINGSMehta, H. B. / Patel, J. / Parikh, R. / Abughosh, S. et al. | 2011
-
PSY57 DOES CLINICAL DIAGNOSIS OF OBESITY INCREASE THE LIKELIHOOD OF RECEIVING OBESITY RELATED COUNSELING? A 2005-2008 NAMCS-NHAMCS ANALYSISKadakia, A. / Mehta, H. / Rajan, S. S. / Abughosh, S. et al. | 2011
-
PSY63 LONGITUDINAL ANALYSIS OF INFLIXIMAB DOSING AND INFUSION INTERVALS ACROSS 30 INFUSIONSCarter, C. / Haas, S. / Gunnarsson, C. / Rizzo, J. / Ingham, M. et al. | 2011
-
PUK7 ECONOMIC EVALUATION OF CINACALCET VERSUS STANDARD TREATMENT IN PATIENTS WITH SECONDARY HYPERPARATHYROIDISM IN MEXICOArocho, R. / Ianazzo, S. / Rivera Hurtado, R. / Paniagua Sierra, J. R. et al. | 2011
-
PMD41 SELECTING A SECONDARY DATA SOURCE FOR A LOW-VOLUME PROCEDURE IN A SPECIALTY POPULATION: A STUDY USING INPATIENT PEDIATRIC COLONOSCOPYAnastassopoulos, K. P. / Knight, T. G. / Baik, R. et al. | 2011
-
PSU6 ANALYSIS OF FACTORS INFLUENCING INPATIENT MORTALITY AND COSTS AMONG PEDIATRIC HEART TRANSPLANTATION RECIPIENTSOlvey, E. L. / Nolan, P. E. / Skrepnek, G. et al. | 2011
-
PSU7 A DISCRETE EVENT SIMULATION MODEL TO ESTIMATE THE LONG TERM OUTCOMES OF BARIATRIC SURGERY IN MEXICOZanela, O. O. / Cabra, H. A. / Anaya, P. / Rodriguez, S. / Melendez, G. et al. | 2011
-
PSU12 IMMUNOSUPPRESSANT THERAPY ADHERENCE AND REJECTION OUTCOMES IN LIVER AND KIDNEY TRANSPLANT PATIENTSGorevski, E. / Minkara, A. / Bain, B. / Mogilishetty, G. / Martin Boone, J. et al. | 2011
-
PMH48 AMBER TODDTodd, A. M. / Zuckerman, I. H. et al. | 2011
-
PDB35 UTILIZATION OF PHYSICIAN, NURSING AND DIETICIAN SERVICES BY TYPE 2 DIABETIC PATIENTS ATTENDING PRIMARY CARE CLINICS IN SINGAPOREToh, M. P. / Wu, C. X. et al. | 2011
-
PDB42 ADHERENCE TO ROUTINE OR STRUCTURED GLUCOSE MONITORING: A QUALITATIVE EVALUATION FROM THE STEP STUDYBergstrom, F. / Whittemore, R. / Schaefer, C. / Christopher, C. A. / Amstutz, L. / Wagner, R. S. et al. | 2011
-
PDB55 CLINICAL AND ECONOMIC EVALUATION OF A DIABETES MEDICATION MANAGEMENT PROGRAM: 2 YEAR PROGRAM UPDATEGorsh, B. / Kim, Y. / Prasla, K. / Tabor, T. / Chaddick, J. / Godley, P. J. et al. | 2011
-
PIH21 COST-UTILITY ANALYSIS OF DIENOGEST VERSUS GNRH ANALOGUE IN THE TREATMENT OF ENDOMETRIOSIS-ASSOCIATED PELVIC PAIN IN SLOVAKIALukac, M. / Knight, C. / Bielik, J. / Tomek, D. / Foltan, V. / Kovac, A. / Bojnicky, M. et al. | 2011
-
PIH31 SELF MEDICATION: ASSESSMENT OF STATUS, PRACTICES AND PERCEPTIONSaleem, F. / Azhar, S. / Al-Qazaz, H. K. / Ahmad, N. / Atif, M. / Haq, N. / Iqbal, Q. / Asif, M. et al. | 2011
-
PIN37 HOW MANY IMMUNIZATION DOSES WERE MISSED IN PEDIATRICES YOUNGER THAN 2 YEARS?Al-lela, O. Q. / Bahari, M. B. / Alabbassi, M. G. / Basher, A. Y. et al. | 2011
-
PIN43 UTILIZATION AND SPENDING OF ANTIFUNGAL AGENTS IN THE UNITED STATES OUTPATIENT MEDICAID POPULATION: 1991-2009Desai, V. C. / Cavanaugh, T. / Guo, J. J. et al. | 2011
-
PIN50 CARE ORGANIZATION AND AMBULATORY CARE SENSITIVE HOSPITALIZATIONS FOR BACTERIAL PNEUMONIAObi, E. N. / Thomas, J. et al. | 2011
-
PMS1 DO BISPHOSPHONATES CAUSE ATYPICAL FEMUR FRACTURES?Mann, J. / Talbert, J. et al. | 2011
-
PMS2 ATRIAL FIBRILLATION IN OSTEOPOROTIC WOMEN TREATED WITH ALENDRONATEChang, L. C. / Kao, Y. H. / Hsiao, F. Y. / Tsai, Y. W. / Huang, W. F. et al. | 2011
-
PMS5 PERSISTENCE WITH BISPHOSPHONATE THERAPY AND RISK OF HIP FRACTUREChodick, G. / Shalev, V. / Sharon, Y. / Goldstein, I. et al. | 2011
-
PMS14 DIRECT HEALTHCARE COSTS ASSOCIATED WITH OSTEOARTHRITISLe, T. K. / Montejano, L. B. / Cao, Z. / Zhao, Y. / Ang, D. et al. | 2011
-
PMS29 COST-UTILITY ANALYSIS OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, LIMITED FASCIECTOMY, AND PERCUTANEOUS NEEDLE FASCIOTOMY IN DUPUYTREN'S CONTRACTURESau, C. / Bounthavong, M. / Tran, J. N. / Wilson, R. L. et al. | 2011
-
PMS41 PATIENT BURDEN OF GOUT: RESULTS FROM THE UNITED STATES NATIONAL HEALTH AND WELLNESS SURVEY (NHWS)Khanna, P. / Forsythe, A. / Annunziata, K. / Khanna, D. et al. | 2011
-
PMS44 ASSESSING VITALITY IN PATIENTS UNDERGOING ETANERCEPT THERAPY FOR RHEUMATOID ARTHRITISGandra, S. R. / Vernon, M. / Cole, J. C. / Bitman, B. / Park, G. S. / Wang, B. / Chaudhari, S. / Fleischmann, R. M. et al. | 2011
-
PMS60 PATIENT OUTCOMES ASSOCIATED WITH BIOLOGIC INFUSION SITE OF CARE FOR THE TREATMENT OF RHEUMATOID ARTHRITISBolge, S. / Ingham, M. / Gupta, S. et al. | 2011
-
PRS10 COST ANALYSIS OF VARENICLINE VERSUS NICOTINE REPLACEMENT THERAPY AND UNAIDED CESSATION IN NICARAGUALutz, M. / Lovato, P. / Cuesta, G. et al. | 2011
-
PRS14 A COST-EFFECTIVENESS ANALYSIS ON THE USE OF INDACATEROL FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN MEXICOBriones, B. / Zuñ / iga, G. / Garcí / a-Contreras, F. et al. | 2011
-
PRS15 ECONOMIC EVALUATION OF FLUTICASONE FUROATE COMPARED WITH MOMETASONA FUROATE FOR THE PRIMARY TREATMENT OF ALLERGIC RHINITIS PATIENTSRely, K. / Alexandre, P. K. / Anaya, P. / Salinas Escudero, G. et al. | 2011
-
PRS19 COST-UTILITY OF VARENICLINE VERSUS INTERVENTIONS AVAILABLE FOR QUITTING SMOKING IN PANAMA USING THE BENESCO MODELLutz, M. / Lovato, P. / Penna, M. / Cuesta, G. et al. | 2011
-
PRS41 A REAL-WORLD EVALUATION OF BETA AGONIST USE DURING HOSPITALIZATIONS FOR COPDRobinson, S. B. / Sarocco, P. / Karafilidis, J. / Walsh, J. / Johnson, B. H. / Ernst, F. R. et al. | 2011
-
PRM3 THE BURDEN OF CAREGIVING: ASSESSING THE STATUS OF CURRENT CLINICAL RESEARCHHamer, N. / Costello, S. / Roper, S. / Hamerslag, L. et al. | 2011
-
PRM5 A REVIEW AND CLASSIFICATION OF CONTINGENT VALUATION METHOD STUDIES IN SUB-SAHARA AFRICAKangethe, A. W. / Franic, D. et al. | 2011
-
PRM14 VALIDATING AN ONLINE CALCULATOR FOR EVALUATING HEALTH INTERVENTION OPTIONS USING THE ANALYTIC HIERARCHY PROCESS (AHP)McGhan, W. F. / Vichaichanakul, K. / Willey, V. J. et al. | 2011
-
PRM10 IS IT FEASIBLE TO COLLECT QUALITY OF LIFE DATA ELECTRONICALLY IN THIN - A UK GENERAL PRACTICE DATABASE?Blak, B. T. / Lee, J. / Thompson, M. / Bourke, A. / Pinder, L. et al. | 2011
-
PRM37 THE DISCRETE MODELLING OF INTERVENTIONS WITH CONTINUOUSLY VARYING COSTS AND EFFECTS: IMPLICATIONS FOR ICERS, CEACS AND EVPIO'Mahony, J. / van Rosmalen, J. et al. | 2011
-
PCN9 VALUE OF RESEARCH ANALYSES IN RESEARCH PRIORITIZATION OF CANCER GENOMIC APPLICATIONSCarlson, J. / Thariani, R. / Roth, J. / Ramsey, S. / Deverka, P. / Esmail, L. / Gralow, J. / Henry, N. L. / Veenstra, D. et al. | 2011
-
PCN30 DOES A LACK OF HTA REVIEW LEAD TO HIGHER PRICES FOR HIV TREATMENTS? A COMPARISON WITH ONCOLOGY TREATMENTSNordyke, R. / Imbeah-Ampiah, R. / Ng-Haing, J. / Oshinowo, B. / Saraf, S. et al. | 2011
-
PCN47 ACUTE LYMPHOCYTIC LEUKEMIA-RELATED INPATIENT CARE AMONG PEDIATRIC PATIENTS IN THE UNITED STATESMitra, D. / Candrilli, S. D. et al. | 2011
-
PCN56 COST-EFFECTIVENESS OF TEMSIROLIMUS FOR METASTIC RENAL-CELL CARCINOMA AND POOR PROGNOSIS PATIENTS IN MEXICOArreola-Ornelas, H. / Rosado-Buzzo, A. / Garcia-Mollinedo, M. / Camacho, L. / Mould-Quevedo, J. F. / Muciñ / o-Ortega, E. / Galindo-Suarez, R. M. et al. | 2011
-
PCN63 EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION TESTING AND FIRST LINE TREATMENT WITH GEFITINIB IS A DOMINANT STRATEGY IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)de Lima Lopes, G. et al. | 2011
-
PCN75 ECONOMIC EVALUATION OF DASATINIB IN CHRONIC MYELOGENOUS LEUKAEMIA PATIENTS RESISTANT TO IMATINIB IN PERU, COMPARED TO NILOTINIB AND HIGH DOSES OF IMATINIBOrozco Giraldo, J. J. / Valencia, J. E. / Garrido Lecca, S. / Aiello, E. C. et al. | 2011
-
PMH2 RISK OF HOSPITALIZATION FOR PNEUMONIA ASSOCIATED WITH THE USE OF ATYPICAL VERSUS TYPICAL ANTIPSYCHOTICS IN A NATIONAL SAMPLE OF MEDICARE BENEFICIARIESDharmarajan, S. H. / Yang, Y. / Athavale, A. S. / Bentley, J. P. / Null, K. D. / Banahan, B. F. et al. | 2011
-
PMH12 THE PROFILE OF IMPAIRMENTS TO ATTENTION AND EPISODIC RECOGNITION MEMORY IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASEWesnes, K. / Lenderking, W. R. et al. | 2011
-
PMH26 MEDICATION ADHERENCE AND HEALTH CARE COSTS AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH DULOXETINEZhao, Y. / Cui, Z. / Fang, Y. / Faries, D. et al. | 2011
-
PMH77 UTILIZATION PATTERN OF PSYCHOTHERAPY AS AN ADJUNCT TO PHARMACOTHERAPY AMONG AMBULATORY BIPOLAR DISORDER PATIENTSMehta, S. / Bhattacharya, R. / Aparasu, R. R. et al. | 2011
-
PMH85 A SCHIZOPHRENIA OR BIPOLAR TYPE I DISORDER REGISTRY: LESSONS LEARNED FROM CONDUCTING A REGISTRY STUDY WITH SAFETY NET PROVIDERSPanish, J. / Dirani, R. / Mark, T. / Montejano, L. B. / Starr, H. L. / Mao, L. et al. | 2011
-
PND26 MEASURING THE IMPACT OF NATALIZUMAB THERAPY ON HEALTH CARE UTILIZATION IN A COMMERCIALY MANAGED MULTIPLE SCLEROSIS POPULATIONPill, M. / Gilkin, B. et al. | 2011
-
PND29 VALIDATION OF THE HUNTINGTON CLINICAL SELF-REPORTED INSTRUMENT (H-CSRI), A CLINIMETRIC PATIENT ASSESSED SCALE FOR PATIENTS WITH HUNTINGTON'S DISEASEClay, E. / Dorey, J. / Toumi, M. / Tedroff, J. / Squitieri, F. / De Nicola, N. / Verny, C. et al. | 2011
-
PND34 MAPPING THE INSOMNIA SEVERITY INDEX (ISI) TO THE EQ-5D UTILITIESGu, N. Y. / Ji, X. / Bell, C. / Botteman, M. et al. | 2011
-
PND40 ASSESSMENT OF PERCEIVED SEVERITY OF DISEASE AND SYMPTOMS, QUALITY OF LIFE, WORK PRODUCTIVITY, AND HEALTH CARE RESOURCE USE IN INDIVIDUALS WITH MULTIPLE SCLEROSISPhillips, A. / Stewart, M. / Edwards, N. / Gupta, S. / Goren, A. et al. | 2011
-
PND47 THE HEMOPHILIA UTILIZATION GROUP STUDY (HUGS-VB): HEALTH-RELATED QUALITY OF LIFE IN HEMOPHILIA BPoon, J. L. / Lou, M. / Doctor, J. / Zhou, Z. Y. / Gwadry-Sridhar, F. / Baker, J. / Ullman, M. / Koerper, M. / Johnson, K. et al. | 2011
-
PND58 INPATIENT HEALTH RESOURCE UTILIZATION AMONG MULTIPLE SCLEROSIS PATIENTS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEMTakemoto, M. M. / Takemoto, M. L. / Fernandes, R. A. / Tolentino, A. C. / Santos, P. M. / Duarte, G. G. / Moretti, A. I. et al. | 2011
-
CN1 MONOTHERAPY OF ANDROGEN DEPRIVATION THERAPY VERSUS RADICAL PROSTATECTOMY AMONG VETERANS WITH LOCALIZED PROSTATE CANCER: A COMPARATIVE EFFECTIVENESS ANALYSIS OF RETROSPECTIVE COHORTSLiu, J. / Shi, L. / Sartor, O. et al. | 2011
-
CO3 PROJECT LIBRA: A NEW ANALYTIC TOOL FOR COMPARATIVE EFFECTIVENESS ANALYSES OF MULTIPAYER CLAIMS DATABASESMark, T. / Pepitone, A. / Hatzmann, M. / Navathe, A. / Goodrich, K. / Chang, S. et al. | 2011
-
DU1 COMPARATIVE SAFETY OF STIMULANT AND ATOMOXETINE ASSOCIATED WITH THE RISK OF SUBSTANCE USE DISORDER AMONG ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDERBhattacharjee, S. / Chen, H. / Bhatara, V. / Aparasu, R. R. et al. | 2011
-
IN1 MEASUREMENT OF SYMPTOMS AND IMPACT OF INFLUENZA: DEVELOPMENT OF THE SYMPTOM INTENSITY AND IMPACT OF INFLUENZA QUESTIONNAIRE (FLU-IIQ)Osborne, R. H. / Norquist, J. / Elsworth, G. / Busija, L. / Mehta, V. / Herring, T. / Gupta, S. et al. | 2011
-
IN4 CARDIOVASCULAR DISEASE SCREENING IN HIV-INFECTED PATIENTS – A COST-EFFECTIVENESS ANALYSISNolte, J. E. / Neumann, T. / Neumann, A. / Manne, J. / Mostardt, S. / Abbara, S. / Brady, T. J. / Hoffmann, U. / Gazelle, G. S. / Wasem, J. et al. | 2011
-
EV2 PAYERS AND PROS: BEYOND QOLMiller, K. L. / Stevens, C. A. et al. | 2011
-
PHP3 FEDERAL ENFORCEMENT ACTIONS AGAINST FRAUD AND ABUSE BY PHARMACEUTICAL MANUFACTURERS: 1996-2010Qureshi, Z. / Sartor, O. / Bennett, C. et al. | 2011
-
PHP27 CANADIAN PUBLIC DRUG PROGRAM SPENDING ON SENIORS, 2002 TO 2008Hunt, J. / Gaucher, M. et al. | 2011
-
PHP37 A REGISTRY PERSPECTIVE OF OF HOSPITAL DISCHARGE COSTS: PILOT RESULTS OF THE 10 MOST FREQUENT DIAGNOSIS AND PROCEDURES OF THE ARGENTINE-HEALTH CARE COST AND UTILIZATION PROJECT (A-HCUP)Insua, J. T. / Giunta, D. / Ioli, P. / Villalon, R. et al. | 2011
-
PHP54 THE IMPACT OF PHARMACIST-CONDUCTED MEDICATION RECONCILIATION WITH PATIENT COUNSELING AT HOSPITAL ADMISSIONChen, C. C. / Huang, Y. F. / Ho, S. W. / Lu, S. H. / Lin, H. Y. / Liu, H. P. et al. | 2011
-
PHP67 UNDERSTANDING THE VIETNAMESE PRICING AND REIMBURSEMENT ENVIRONMENT THROUGH A COMPARISON WITH THAT OF CHINALewis, S. / Dummett, H. et al. | 2011
-
PHP76 THE OUTLOOK OF LARGE SIMPLE TRIALS FOR COMPARATIVE EFFECTIVENESS RESEARCH: AN APPLICATION OF THE PRECIS FRAMEWORKVincent, L. et al. | 2011
-
DM4 EVALUATION OF CLINICAL LABORATORY-PHARMACY LINKAGE DECISION SUPPORT IN THE USE OF POTASSIUM SUPPLEMENTSYu, S. / Galanter, W. / Lin, F. J. / Lambert, B. et al. | 2011
-
OR4 ASSOCIATIONS BETWEEN JOBLESSNESS AND ALL-CAUSE HEALTH SERVICES UTILIZATION IN DIABETIC WORKING AGE ADULTS IN THE UNITED STATESDavis-Ajami, M. L. / Nahata, M. / Seiber, E. / Reardon, G. / Balkrishnan, R. et al. | 2011
-
CE2 A NOVEL WAY OF ESTIMATING COST-EFFECTIVENESS RATIOS FROM CLINICAL TRIALS WITH MISSING DATA: A SIMULATION STUDYGagnon, D. D. / Engelhart, L. et al. | 2011
-
MC1 COMPARISON OF REFILL GAP ANALYSIS METHODOLOGIES IN A POPULATION OF PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ADALIMUMAB OR ETANERCEPTCarter, C. / Bolge, S. / Ingham, M. / Schmeichel-Mueller, C. et al. | 2011
-
MD2 PRESCRIPTION DRUG COST AND USE IN THE MEDICARE PART D POPULATION - USES OF A NEW LIMITED DATA SETPowers, C. A. / Varghese, A. / Hsu, V. D. / O'Donnell, J. / Schneider, K. et al. | 2011
-
PHP6 EXPLORE THE USE OF DRUGS IN MEDICAL INSURANCE BILLING IN CHINATan, Z. et al. | 2011
-
PHP19 TRENDS IN ON-LABEL AND OFF-LABEL PRESCRIBING OF MONTELUKAST IN A COMMERCIALLY INSURED POPULATION 1998-2008Ali, M. M. / Martin, B. et al. | 2011
-
PHP22 ASSOCIATION OF SELF-REPORTED HEALTH STATUS WITH COST-RELATED MEDICATION NONADHERENCE AND OUT-OF-POCKET PHARMACY SPENDING AMONG SENIOR MEDICARE BENEFICIARIESTang, Y. et al. | 2011
-
PHP43 THE INFLUENCE OF PATIENT ACCESS SCHEMES ON APPRAISAL DECISIONS BY NICE IN THE UNITED KINGDOMTimm, B. / Kusel, J. / Hamer, N. / Costello, S. et al. | 2011
-
PHP44 DURATION OF PATIENTS VISITS TO THE EMERGENCY DEPARTMENTKaraca, Z. / Wong, H. / Mutter, R. et al. | 2011
-
PHP56 DEMONSTRATING CLINICAL-EFFECTIVENESS USING INDIRECT AND MIXED TREATMENT COMPARISON ANALYSIS: A REVIEW OF MANUFACTURERS' SINGLE TECHNOLOGY APPRAISAL (STA) SUBMISSIONS TO THE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (NICE)Bending, M. W. / Hutton, J. / McGrath, C. et al. | 2011
-
PHP65 HEALTH OUTCOMES AND ECONOMICS RESEARCH FOR CELLULAR THERAPIES AND REGENERATIVE MEDICINES: LESSONS FROM A HEALTH TECHNOLOGY ASSESSMENT AND REIMBURSEMENT ANALYSIS IN THE UNITED STATESFaulkner, E. C. / Spinner, D. S. et al. | 2011
-
PHP75 USE OF ELECTRONIC MEDICAL RECORDS FROM 2001 THROUGH 2010: IMPLICATIONS FOR COMPARATIVE EFFECTIVENESS RESEARCHAnastassopoulos, K. P. / Mann, R. / Knight, T. G. / Sudharshan, L. / Ackerman, S. J. et al. | 2011
-
PHP81 CAREGIVER WELL-BEING AND HEALTH CARE ACCESS AND QUALITY AMONG CHILDREN WITH CHRONIC PHYSICAL AND MENTAL CONDITIONSRane, P. / Sambamoorthi, U. et al. | 2011
-
PCV7 ANALYSIS OF TREATMENT PATTERNS AND COSTS FOR VENOUS THROMBOEMBOLISM, MAJOR AND MINOR BLEEDING EVENTS IN HOSPITALIZED MEDICALLY ILL PATIENTSBaser, O. / Xie, L. / Du, J. / Wang, L. et al. | 2011
-
PHP114 OPTIMIZING THE ORGANIZATION; MIGRATING HEALTH SERVICES RESEARCH OPERATIONS INTO THE COLLABORATIVE SCIENCE CENTER OF EXCELLENCEBenson, J. / Enterline, L. et al. | 2011
-
PCV12 IMPACT OF POTENTIAL DRUG-DRUG INTERACTIONS (DDIS) ON HEALTH OUTCOMES AND COST TO MEDICAID: THE MONETARY BENFITS OF QUALITY HEALTH CAREAthavale, A. S. / Banahan, B. F. / Mendonca, C. M. et al. | 2011
-
PCV17 PREDICTORS OF TIME TO DISCONTINUE BETA-BLOCKER FOLLOWING ACUTE MYOCARDIAL INFARCTION: AN ANALYSIS OF THE MEDICARE 5% NATIONAL SAMPLE DATA 2006-2007Lokhandwala, T. / Yang, Y. / Thumula, V. / Bentley, J. P. / Strum, M. / Banahan, B. F. / Null, K. et al. | 2011
-
PCV26 EFFECTS OF THIAZOLIDINEDIONES ON CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE-2 DIABETES MELLITUS AFTER DRUG-ELUTING STENT IMPLANTATIONYeh, S. Z. / Hsieh, C. F. / Tsai, Y. W. / Huang, W. F. et al. | 2011
-
PCV49 COST-EFFECTIVENESS ANALYSIS OF RIVAROXABAN VERSUS DABIGATRAN AND ENOXAPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL KNEE REPLACEMENTVorobyev, P. / Krasnova, L. / Borisenko, O. / Lukyantseva, D. / Bashlakova, E. et al. | 2011
-
PCV112 EXTENSION OF META-ANALYSIS IN COMPARING OF FIMASARTAN WITH LOSARTAN IN BLOOD PRESSURE LOWERING EFFECTNa, Y. / Lee, E. K. et al. | 2011
-
PSS12 A DISCRETE EVENT SIMULATION TO OPTIMISE THE ALLOCATION OF CONSTRAINED HOSPITAL RESOURCES FOR GLAUCOMACrane, G. J. / Karnon, J. / Kymes, S. / Casson, R. / Metcalfe, A. / Hiller, J. E. et al. | 2011
-
PSS16 DEVELOPMENT OF A DISEASE SPECIFIC VERSION OF THE EQ-5D FOR USE IN PSORIASISLloyd, A. / Swinburn, P. / Boye, K. S. / Edson, E. / Bowman, L. et al. | 2011
-
PSS26 PATIENT'S EVALUATION OF THE QUICKNESS OF ACTION OF GINGIVAL INFLAMMATION TREATMENTSMattout, P. / Rahhali, N. / Watt, M. / Auges, M. / Taieb, C. et al. | 2011
-
PSS23 COMPARING HEALTH-RISK BURDEN AND TOTAL HEALTHCARE COSTS OF PSORIASIS WITH TOP FIVE CHRONIC CONDITIONSNaim, A. / Pitts, J. / Chen, C. Y. / Wright, D. / Chalk, M. B. / Edington, D. et al. | 2011
-
PSY22 ANALYSING THE BENEFITS AND COST SAVING OF ORAL VERSUS IV FLUDARABINE FOR MANAGEMENT OF B-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL)Zinzani, P. L. / Connors, J. M. / Knight, A. D. / Crowe, A. M. / Jones, R. / Tucker, B. et al. | 2011
-
PSY28 FACTORS LEADING TO HIGH HEALTH CARE EXPENDITURE AMONG OBESE INDIVIDUALS IN THE UNITED STATESPatel, J. G. / Aparasu, R. R. / Rajan, S. S. / Johnson, M. L. et al. | 2011
-
PSY62 PERCEIVED BENEFITS AND DISADVANTAGES OF INTRAVENOUS (IV) BIOLOGIC THERAPY AMONG PATIENTS WITH IMMUNOLOGY CONDITIONSBolge, S. / Vanderpoel, J. / Eldridge, H. / Mody, S. / Lofland, J. / Ingham, M. et al. | 2011
-
PSY72 VARIATION BY AGE IN HEALTH-RELATED QUALITY OF LIFE OF PATIENTS INITIATING TREATMENT FOR MYELODYSPLASTIC SYNDROMESPashos, C. / Grinblatt, D. L. / Komrokji, R. S. / Sekeres, M. A. / Narang, M. / Sullivan, K. A. / Street, T. K. / Khan, Z. M. et al. | 2011
-
PSY76 TREATMENT OF CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS) KNOWLEDGE STUDY (TOCKS): NOVEL DATA COLLECTION, VIEWING AND DYNAMIC REPORTING MECHANISMArnold, R. J. / Groesser, K. et al. | 2011
-
PUK10 KIT73 STUDY: RELATIONSHIP BETWEEN COSTS OF CARE AND 12-MONTH GLOMERULAR FILTRATION RATES IN POST-KIDNEY TRANSPLANT PATIENTS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM (SUS)David-Neto, E. / Esmeraldo, R. M. / Asano, E. / Nita, M. E. / Nishikawa, A. M. / Barbosa, E. / Szabo, S. M. / Levy, A. R. / Carvalho, J. F. / Donato, B. M. et al. | 2011
-
PUK18 THE IMPACT OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) ON PATIENTS' HEALTH RELATED QUALITY OF LIFE (HRQOL): DEVELOPMENT OF A CONCEPTUAL FRAMEWORKCole, J. C. / Krasa, H. B. / Cheng, R. / Oberdhan, D. / Urwongse, J. / Schaefer, C. / Czerwiec, F. et al. | 2011
-
PMD25 THE COST-UTILITY AND VALUE OF INFORMATION OF TRANSCATHETER AORTIC VALVE IMPLANTATION COMPARED TO STANDARD MANAGEMENT AND SURGICAL AORTIC VALVE REPLACEMENT IN PATIENTS WITH SEVERE SYMPTOMATIC AORTIC VALVE STENOSISDoble, B. M. / Perampaladas, K. / von Keyserlingk, C. / Campbell, K. / Blackhouse, G. / Goeree, R. / Xie, F. et al. | 2011
-
PSU5 LONG-TERM CLINICAL SAFETY OF LASIK AND SURFACE ABLATION IN SOUTH KOREA THROUGH LINKAGE OF RETROSPECTIVE COHORT AND NATIONWIDE CLAIMS DATABASELee, E. J. / Choi, J. E. / Jung, S. Y. / Jang, E. J. / Lee, N. R. / Joo, C. K. et al. | 2011
-
PSU23 ASSESSING THE OUTCOME OF SHOULDER SURGERY: DEVELOPMENT, VALIDATION AND RESPONSIVENESS OF THE PATIENT-REPORTED OXFORD SHOULDER SCORE (OSS)Dawson, J. / Fitzpatrick, R. / Carr, A. J. / Churchman, D. et al. | 2011
-
PSU24 AGREEMENT BETWEEN PROMIS DEPRESSION, SLEEP DISTURBANCE, AND FATIGUE CAT MEASURES AND SF-36 SCORES IN A CLINICAL COHORTNerenz, D. R. / Pietrantoni, L. / Schultz, L. / Obeid, L. / Swartz, A. / Rubinfeld, I. / Velanovich, V. et al. | 2011
-
PDB4 MODELING HEALTH AND ECONOMIC OUTCOMES ASSOCIATED WITH EXENATIDE ONCE-WEEKLY VERSUS INSULIN AND PIOGLITAZONE TREATMENT FOR TYPE-2 DIABETESGaebler, J. A. / Soto-Campos, G. / Alperin, P. E. / Hoogwerf, B. J. / Wintle, M. / Maggs, D. / Han, J. / Blickensderfer, A. / Pencek, R. / Bruhn, D. et al. | 2011
-
PDB13 USE OF ANTIDEPRESSANTS AND THE RISK OF DIABETES MELLITUS: A RETROSPECTIVE COHORT STUDYKhoza, S. / Barner, J. C. / Lawson, K. / Rascati, K. L. / Wilson, J. P. / Bohman, T. M. et al. | 2011
-
PDB26 ECONOMIC EVALUATION OF GLIMEPIRIDE AND GLIMEPIRIDE/METFORMIN FOR TYPE-2 DIABETES MELLITUS IN MEXICOCarlos, F. / Lemus, A. et al. | 2011
-
PDB44 A NOVEL APPROACH FOR NON-ADHERENCE MEASUREMENT BASED ON PRESCRIPTION DATA: THE EXAMPLE OF ORAL DIABETICS IN THE THERAPY OF TYPE-2 DIABETES MELLITUS PATIENTSWilke, T. / Mueller, S. / Lindner, R. / Ahrens, S. / Verheyen, F. et al. | 2011
-
PDB45 THE PATIENT REPORTED EXPERIENCE OF LIVING WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN (DPNP)Brod, M. / Carson, R. / Ramasamy, A. / Setyawan, J. et al. | 2011
-
PDB52 A LITERATURE REVIEW OF DIABETES RISK ASSESSMENT TOOLSThoopputra, T. / Li, S. / Newby, D. / Schneider, J. et al. | 2011
-
PDB68 ASSESSING LIFEYEARS SAVED FROM 2000 TO 2010 IN CHINA DUE TO NOVO NORDISK INSULINHenriksen, O. / Jain, P. / Nielsen, O. K. et al. | 2011
-
PIH2 LEAD DETOXIFYING EFFECT OF VITAMIN C IN TRAFFIC POLICE SUBJECTSGilani, A. H. / Fazal, O. / Shah, A. J. / Mehmood, M. H. / Tariq, S. A. et al. | 2011
-
PIH10 HEALTH CARE RESOURCE UTILIZATION AND COSTS IN FEMALES WITH NEWLY DIAGNOSED HEAVY MENSTRUAL BLEEDING: AN EMPLOYER'S PERSPECTIVEJensen, J. T. / Lefebvre, P. / Laliberté / F. / Sarda, S. P. / Law, A. / Pocoski, J. / Duh, M. S. et al. | 2011
-
PIH8 THE ECONOMIC IMPACT ATTRIBUTABLE TO THE INAPPROPRIATE PRESCRIPTION OF BENZODIAZEPINES IN THE ELDERLY LIVING IN THE COMMUNITYDionne, P. A. / Vasiliadis, H. M. / Pré / ville, M. et al. | 2011
-
PIH30 POSTPARTUM DEPRESSION IN VULNERABLE PEOPLE IN SOUTH KOREAKim, B. H. / Choi, J. E. / Jeon, H. W. / Kim, J. A. / Sim, Y. H. / Kim, S. H. / Lee, K. J. / Jung, B. Y. / Kim, J. K. / Lee, D. S. et al. | 2011
-
PIH34 IMPLEMENTATION OF A STATE MEDICAID PRESCRIPTION CAP POLICY: IS THERE AN IMPACT ON BENEFICIARIES' MEDICAL SERVICES UTILIZATION AND COSTS?Khanna, R. / Dharmarajan, S. H. / Null, K. D. / Bentley, J. P. / Pace, P. F. / Banahan, B. F. et al. | 2011
-
PIN4 EFFICACY AND SAFETY OF THE COMBINATION EFAVIRENZ (EFV), TENOFOVIR (TDF) AND EMTRICITABINE (FTC) ONCE A DAY IN TREATMENT OF NAïVE ADULT PATIENTS WITH HIV-1 INFECTION: A SYSTEMATIC REVIEWRizzoli-Cordoba, A. / Delgado-Ginebra, I. et al. | 2011
-
PIN26 A COST-EFFECTIVENESS ANALYSIS ON THE USE OF DAPTOMYCIN FOR THE TREATMENT OF BACTEREMIA AND INFECTIVE ENDOCARDITIS IN PATIENTS WITH METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTION IN MEXICOGarcí / a-Contreras, F. / Martinez Revelles, M. / Briones, B. et al. | 2011
-
PIN30 COST EFFECTIVENESS ANALYSIS OF THE COMBINATION EFAVIRENZ (EFV), TENOFOVIR (TDF) AND EMTRICITABINE (FTC) ONCE A DAY IN TREATMENT OF NAïVE ADULT PATIENTS WITH HIV INFECTION IN MEXICORizzoli-Cordoba, A. / Delgado-Ginebra, I. / Pizarro-Castellanos, M. / Castillo, J. J. et al. | 2011
-
PMS7 THE IMPACT OF RHEUMATOID ARTHRITIS ON CARDIOVASCULAR MORBIDITY IN A HIGH RISK MEDICAID POPULATIONShaya, F. T. / Yan, X. / Johnson, W. R. et al. | 2011
-
PMS20 HEALTH CARE RESOURCES UTILIZATION IN THE MANAGEMENT OF JUVENILE IDIOPATHIC ARTHRITIS: ANALYSES WITH THE RAMQ DATABASELachaine, J. / Beauchemin, C. / Martel, M. J. / Goyette, A. et al. | 2011
-
PMS45 WILLINGNESS TO PAY FOR OSTEOPOROSIS TREATMENT TO PREVENT FRACTURE IN KOREAN POPULATIONSuh, H. S. / Kim, Y. / Park, J. / Park, S. / Hyun, M. K. / Ahn, J. et al. | 2011
-
PMS48 IMPACT OF ANTI-TNF ON HEALTH CARE UTILIZATION AND COSTS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN ALBERTA, CANADAOhinmaa, A. / Thanh, N. X. / Martin, L. / Russell, A. / Barr, S. / Shelter, D. / Penney, C. / Yan, C. / Maksymowych, W. et al. | 2011
-
PMS52 PREDICTORS OF BISPHOSPHONATE PRESCRIPTION IN PATIENTS WITH OSTEOPOROSISPatel, A. V. / Wu, I. H. / Ho, L. / Aparasu, R. R. et al. | 2011
-
PRS21 RESOURCE USE AND COSTS OF EXACERBATION MANAGEMENT OF CHRONIC OBSTRUTIVE PULMONARY DISEASE PATIENTS UNDER THE PRIVATE HEALTHCARE SYSTEM IN BRAZIL: ROLE OF MAINTENANCE TREATMENT IN THE EXACERBATION PREVENTION IN SEVERE PATIENTSNasciben, V. et al. | 2011
-
PRM38 THE EXTENSION OF THE COST-EFFECTIVENESS ACCEPTABILITY CURVE: HOW TO MAKE IT MORE INFORMATIVE?Kamae, I. / Araki, D. / Kamae, M. et al. | 2011
-
PCN21 PATTERNS OF ANGIOGENESIS INHIBITOR TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) IN IRELANDMcDermott, R. / Donnellan, P. / McCaffery, J. / Keane, F. / Sarda, S. P. / Korves, C. / Luka, A. / Wei, R. / Neary, M. P. / Hanley, R. et al. | 2011
-
PCN29 TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) USING RITUXIMAB (R) WITH FLUDARABINE (F) AND CYCLOPHOSPHAMIDE (C): ASSESSING THE FINANCIAL IMPACT OF THE ROUTE OF ADMINISTRATION AT PRINCESS MARGARET HOSPITAL (PMH)Douglas, P. / Lee, R. / Worthington, K. / Mistry, B. et al. | 2011
-
PCN38 FIRST-YEAR COSTS FOR THE 19 MOST COMMON CANCER DIAGNOSES IN ONTARIOde Oliveira, C. / Bremner, K. / Chan, K. / Gunraj, N. / Krahn, M. et al. | 2011
-
PCN41 FINANCIAL BURDEN AMONG PATIENTS WITH MAJOR CANCERS: FINDINGS FROM THE UNITED STATES MEDICAL EXPENDITURE PANEL SURVEY, 1996-2007Lang, K. / Huang, H. / Rodriguez, L. / Menzin, J. et al. | 2011
-
PCN61 COST-EFFECTIVENESS OF 1-YEAR ADJUVANT TRASTUZUMAB THERAPY FOR EARLY STAGE OF HER2-POSITIVE BREAST CANCERNguyen, T. T. / Yagudina, R. / Kulikov, A. U. et al. | 2011
-
PCN83 A COMPARISON OF PREFERENCES FOR TARGETED THERAPY FOR METASTATIC RENAL CELL CARCINOMAPark, M. H. / Lee, E. K. et al. | 2011
-
PCN108 CLINICAL EFFICACY AND ONCOLOGY REIMBURSEMENT RECOMMENDATIONS IN CANADA BY THE INTERIM JOINT ONCOLOGY DRUG REVIEW (IJODR)Ciapanna, C. C. / Shum, D. / Milliken, D. / Yunger, S. et al. | 2011
-
PCN107 PAYER-RATED VALUE OF PAIN IMPROVEMENT IN CASTRATION-RESISTANT PROSTATE CANCER: TRADEOFFS BETWEEN SURVIVAL, PAIN AND ANALGESIC USESchneider, J. / Beusterien, K. / Ohsfeldt, R. / Brown, J. / Boye, M. E. / Ebeid, O. / Hill, J. et al. | 2011
-
PGI16 RESOURCE UTILIZATION AND HEALTH CARE COSTS ASSOCIATED WITH DIVERTICULAR DISEASE: RESULTS FROM A RETROSPECTIVE CLAIMS DATABASE ANALYSIS IN THE UNITED STATESYen, L. / Davis, K. / Longstreth, G. / Streck, P. / Hodgkins, P. et al. | 2011
-
PGI15 COST EFFECTIVENES OF THE PHARMACOLOGIC TREATMENT OF IRRITABLE BOWEL SYNDROME AT THE SOCIAL SECURITY MEXICAN INSTITUTEOjeda Mé / ndez, J. / Contreras, I. / Vallejos Pará / s, A. et al. | 2011
-
PMH13 COMPARATIVE EFFECTIVENESS STUDY OF RISPERIDONE LONG-ACTING INJECTABLE: THE USE OF DYNAMIC EXPOSURE METHODOLOGY FOR RISK SHARING AGREEMENTGrimaldi-Bensouda, L. / Rouillon, F. / Abenhaim, L. et al. | 2011
-
PMH18 IMPACT OF COGNITIVE IMPAIRMENT ON FUNCTIONING, MEDICAL RESOURCE UTILIZATION, ADHERENCE AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH SCHIZOPHRENIALin, F. J. / Bhor, M. / Hass, S. / Perry, R. / Kay, S. et al. | 2011
-
PMH20 PSYCHOTROPIC MEDICATION USE AMONG CHILDREN WITH AUTISM SPECTRUM DISORDER: A COMPARISON BETWEEN MEDICAID AND COMMERCIAL INSURANCEWang, L. / Leslie, D. et al. | 2011
-
PMH42 ECONOMIC EVALUATION OF DESVENLAFAXINE IN THE ACUTE MANAGEMENT OF ASSOCIATED MAJOR DEPRESSIVE DISORDER IN MEDICALLY ILL INPATIENTS FROM A BRAZILIAN PUBLIC GENERAL HOSPITAL PERSPECTIVEScaccabarozzi, L. / Takemoto, M. L. / Fernandes, R. A. / Santos, P. M. / Tolentino, A. C. et al. | 2011
-
PND12 LOWER DAILY AVERAGE CONSUMPTION AND GREATER PRESCRIPTION COST SAVINGS OF ARMODAFINIL COMPARED WITH MODAFINIL: A 12-MONTH RETROSPECTIVE DATABASE ANALYSISCarlton, R. / Regan, T. S. / Rice, G. et al. | 2011
-
PND30 QUALITY OF LIFE AMONG PATIENTS SUFFERING FROM MIGRAINE: HEALTH UTILITY BY FREQUENCY OF HEADACHE DAYSGillard, P. / Devine, B. / Bloudek, L. M. / Liu, L. / Varon, S. F. / Lipton, R. B. / Sullivan, S. D. et al. | 2011
-
PND49 MEASUREMENT CHARACTERISTICS OF THE SF-36 IN PARKINSON'S DISEASEBanks, P. / Martin, C. R. et al. | 2011
-
PHP94 THE ROLE OF HEALTH-RELATED QUALITY OF LIFE DATA IN THE DRUG APPROVAL PROCESSES IN THE UNITED STATES AND EUROPE: A REVIEW OF GUIDANCE DOCUMENTS AND AUTHORIZATIONS OF MEDICINAL PRODUCTS FROM 2006 TO 2010Marquis, P. / Caron, M. / Emery, M. P. / Scott, J. / Acquadro, C. et al. | 2011
-
PHP108 THE CASE OF RARE DISEASE DRUGS BEFORE AND AFTER THE INTRODUCTION OF PRICING BODIES: LESSONS LEARNED FROM BRAZIL AND CANADA, IMPLICATIONS FOR THE UNITED STATESCost, P. / Snyder, T. / Zaidi, Q. et al. | 2011
-
PHP109 AN OUTCOMES PROFILE REGISTRY FOR ESTABLISHING A BASELINE MATRIX IN COMPARATIVE EFFECTIVENESS STUDIES IN PREDICTIVE PHARMACOLOGYWheeler, C. et al. | 2011
-
PCV13 BURDEN OF COMORBIDITIES AMONG PATIENTS WITH ATRIAL FIBRILLATIONLaMori, J. C. / Gross, H. J. / Patel, A. A. / Crain, M. / DiBonaventura, M. D. / Mody, S. H. / Schein, J. et al. | 2011
-
PCV23 COMPARING THE EFFECTIVENESS OF ROSUVASTATIN AND ATORVASTATIN IN PREVENTING CARDIOVASCULAR OUTCOMES: ESTIMATES USING THE ARCHIMEDES MODELSchuetz, C. A. / van Herick, A. / Alperin, P. / Peskin, B. / Hsia, J. / Gandhi, S. K. et al. | 2011
-
PCV30 A META-ANALYSIS OF RISK FACTORS TO DEVELOP CARDIOVASCULAR EVENTS AND STROKE IN SUBJECTS EXPOSED TO ENVIROMENTAL TOBACCO SMOKEVillasis-Keever, M. / Rendó / n-Macias, M. / Escamilla_Nuñ / ez, A. / Mould-Quevedo, J. F. / Muciñ / o-Ortega, E. / Galindo-Suarez, R. M. et al. | 2011
-
PCV38 POTENTIAL ECONOMIC IMPACT OF DYSPNEA ASSOCIATED WITH TICAGRELOR USEBonafede, M. / Jing, Y. / Gdovin Bergeson, J. / Liffmann, D. K. / Makenbaeva, D. / Graham, J. P. / Deitelzweig, S. et al. | 2011
-
PCV39 CHARACTERIZATION OF COSTS ASSOCIATED WITH STROKE REHABILITATION: A REVIEW OF THE LITERATURESacco, P. / Johnson, J. / Verma, A. et al. | 2011
-
PCV46 LONG-TERM COSTS AND HEALTH OUTCOMES OF TREATING ACUTE CORONARY SYNDROME PATIENTS WITH TICAGRELOR BASED ON THE EU LABEL - COST-EFFECTIVENESS ANALYSIS BASED ON THE PLATO STUDYHenriksson, M. / Nikolic, E. / Janzon, M. / Hauch, O. / Levin, L. x. / Wallentin, L. et al. | 2011
-
PCV56 COST-MINIMIZATION ANALYSIS OF LANDIOLOL FOR CT SCANNING FOR CVD SUSPICIOUS PATIENTS IN JAPANIgarashi, A. / Fujito, K. / Fukuda, T. et al. | 2011
-
PCV66 ADHERENCE RATES AMONG HEALTH PLAN MEMBERS STARTING GENERIC VERSUS BRAND STATIN THERAPYChen, Q. / Kachur, S. G. / Fatodu, H. / Garber, H. et al. | 2011
-
PCV91 BETA BLOCKERS AND DIURETICS USAGE IN CROATIA AND SLOVENIA DURING A NINE-YEAR PERIODVitezic, D. / Kucan, M. / Vitezic, M. / Kovacevic, M. / Mrsic Pelcic, J. et al. | 2011
-
PCV94 ANTICOAGULANT USE, THE PREVALENCE OF BRIDGING AND RELATION TO LENGTH OF STAY AMONG HOSPITALIZED PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATIONSmoyer-Tomic, K. / Sander, S. / Siu, K. / Smith, D. M. / Amin, A. / Johnson, B. H. et al. | 2011
-
PCV104 REAL-WORLD SIDE EFFECT DATA ON CHOLESTEROL MEDICATIONS – OUTPUTS FROM AN ONLINE PATIENT COMMUNITYCascade, E. / Plummer, R. C. / Mangini, N. S. et al. | 2011
-
PCV108 CARDIOVERSION TREATMENT PATTERNS AND OUTCOMES AMONG ACUTE ATRIAL FIBRILLATION PATIENTS IN 5 EUROPEAN COUNTRIESBuono, J. L. / Russell, T. / Worsfold, A. / Bash, L. D. et al. | 2011
-
PSS13 INCREMENTAL COST-UTILITY ANALYSIS OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA FOLLOWING RETINAL VEIN OCCLUSIONKowalski, J. / Yeh, W. S. / O'Leary, B. / Ackerman, S. / Sharma, S. / Adena, M. et al. | 2011
-
PSS17 THE EFFECT OF ORAL CP-690,550 ON PRURITUS IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASISMamolo, C. M. / Bushmakin, A. G. / Cappelleri, J. C. / Stewart, M. et al. | 2011
-
PSS22 SYSTEMATIC REVIEW OF THE QUALITY OF LIFE LITERATURE IN CHILDREN WITH ATOPIC DERMATITISIskedjian, M. / Navarro, V. / Khondoker, F. / Farah, B. et al. | 2011
-
PSS27 EFFECT OF TREATMENT SWITCH ON THE COST-EFFECTIVENESS OF BIOLOGICS IN PSORIASIS IN PERU AND COLOMBIAAlandete, J. C. et al. | 2011
-
PSS29 DEVELOPMENT OF THE MODIFIED OCULAR COMFORT INDEX (MOCI)Johnson, M. E. / Ruiz, W. M. / Li, J. Z. et al. | 2011
-
PSY1 SEVERE RENAL, HEPATIC AND GASTROINTESTINAL EVENTS ASSOCIATED WITH DEFERASIROX IN PATIENTS WITH TRANSFUSION-DEPENDENT ANEMIAHuang, W. F. / Hsiao, F. Y. / Chou, H. C. / Tsai, Y. W. / Yen, H. C. / Ke, W. M. et al. | 2011
-
PSY18 A DECISION ANALYSIS MODEL EXPLORING THE RESULTS OF A PHASE II TRIAL OF ELTROMBOPAG FOR PATIENTS WITH CHRONIC HEPATITIS C, CIRRHOSIS AND THROMBOCYTOPENIASchelfhout, J. / Kauf, T. et al. | 2011
-
PSY33 EXPLORING THE FACTOR STRUCTURE OF THE PROMIS FATIGUE ITEM BANK IN PATIENTS WITH FIBROMYALGIASchilling, S. / Blum, S. I. / Tourkodimitris, S. / Williams, D. A. et al. | 2011
-
PSY48 A WORKPLACE HEALTH PROGRAM FOR BRITISH COLUMBIA PUBLIC SERVICE AGENCY (CANADA)Tarride, J. E. / Harrington, K. / Balfour, R. / Simpson, P. / Foord, L. / Anderson, L. / Lakey, W. K. et al. | 2011
-
PSY61 CHARACTERISTICS OF GOLIMUMAB UTILIZATION AND COSTS IN A SPECIALTY PHARMACY PROVIDER (SPP) SETTINGEllis, L. / Tandon, N. / Mody, S. / Doshi, D. / Baek, C. / Gunnarsson, C. et al. | 2011
-
PSY71 HEALTH AND FUNCTIONAL STATUS FOR INDIVIDUALS WITH THROMBOCYTOPENIA IN THE UNITED STATES: EVIDENCE FROM NHANESKauf, T. / Schelfhout, J. / Nelson, D. R. / Wang, P. F. et al. | 2011
-
PSY68 DEFINITIONS OF ANTI-TNF DISCONTINUATION MAY IMPACT UNDERSTANDING OF REAL-WORLD UTILIZATION PATTERNSSchmeichel-Mueller, C. / Buysman, E. / Bolge, S. / Ingham, M. / McKenzie, R. S. et al. | 2011
-
PSY78 ESTIMATING THE BMI-MORTALITY RELATION USING FRACTIONAL POLYNOMIALSWong, E. / Wang, B. C. / Garrison, L. / Alfonso-Cristancho, R. / Flum, D. / Arterburn, D. / Sullivan, S. D. et al. | 2011
-
PMD38 META ANALYSIS OF THE IMPACT OF HEALTH INFORMATION TECHNOLOGY ON MEDICATION SAFETY IN HOSPITALS: AN INTERRUPTED TIME SERIES STUDYChang, J. / Patel, I. / Kim, B. / Kwon, I. / Balkrishnan, R. et al. | 2011
-
PMD39 MINI-HTA TRENDS FOR MEDICAL DEVICES IN THE NORDICSGrundstrom, J. P. / Friberg, S. / Medin, E. et al. | 2011
-
PSU3 LONG-TERM CLINICAL EFFECTIVENESS AND STABILITY OF LASIK AND SURFACE ABLATION IN KOREA: A SYSTEMATIC REVIEW APPROACHLee, N. R. / Choi, J. / Jang, E. J. / Jung, S. Y. / Lee, E. J. / Joo, C. K. et al. | 2011
-
PSU8 PATTERNS OF ACUTE CLOPIDOGREL USE AND INPATIENT COSTS IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFTINGJohnston, S. S. / Bell, K. / Gdovin Bergeson, J. / McMorrow, D. / Graham, J. et al. | 2011
-
PSU17 EXCESS PAYMENTS FROM MEDICARE FOR INPATIENT SURGERYBaser, O. et al. | 2011
-
PDB21 A COST COMPARISON OF A BASAL BOLUS REGIMEN (INSULIN GLARGINE AND INSULIN GLULISINE) WITH A CONVENTIONAL PRE-MIXED INSULIN REGIMEN IN TYPE-2 DIABETES PATIENTS – THE GINGER STUDYTilling, C. / Vora, J. / Keech, M. et al. | 2011
-
PDB38 A COMPARISON OF INSULIN ADHERENCE IN PATIENTS WITH TYPE-2 DIABETES INITIATING THERAPY WITH INSULIN DETEMIR FLEXPEN® OR NPH INSULIN IN A VIALBuysman, E. / Conner, C. / Liu, F. / Aagren, M. / Bouchard, J. et al. | 2011
-
PDB71 CHARACTERISTICS OF EARLY ADOPTERS OF EXPENSIVE MEDICATIONSJuarez, D. T. / Davis, J. / Fujimoto, R. / Chung, R. S. et al. | 2011
-
PIH3 COMPARISON OF IN VITRO FERTILIZATION TRENDS AMONG INSURED PATIENTS IN MANAGED CARE IN THE UNITED STATES; COMPARISON OF STATES WITH AND WITHOUT MANDATED COMPREHENSIVE FERTILITY COVERAGEFincher, C. / Kozma, C. / Hubbard, J. / Meletiche, D. M. / Velez, F. F. et al. | 2011
-
PIH16 COST-EFFECTIVENESS OF DESVENLAFAXINE FOR THE TREATMENT OF VASOMOTOR SYMPTOMS IN BREAST CANCER PATIENTS IN MEXICORamí / rez-Ramí / rez, M. A. / Peniche-Otero, G. / Mould-Quevedo, J. F. / Nuñ / o-Langre, C. / Muciñ / o-Ortega, E. / Galindo-Suarez, R. M. et al. | 2011
-
PIH22 PRIMARY MEDICATION NONADHERENCE: A RETROSPECTIVE ANALYSIS OF ELECTRONIC PRESCRIPTIONS IN AN INTEGRATED HEALTHCARE SETTINGShin, J. / Cheetham, C. T. / Sanchez, R. J. / Deminski, M. C. / Udall, M. / Vansomphone, S. S. / McCombs, J. et al. | 2011
-
PIH46 SPECIAL PRECAUTIONS TO CONSIDER WHEN PERFORMING COGNITIVE DEBRIEFING OF SENSITIVE TOPICSGawlicki, M. / Handa, M. / McKown, S. et al. | 2011
-
PIN15 ECONOMIC BURDEN OF SURGICAL SITE INFECTIONS IN HIP AND KNEE ARTHROPLASTY - A COST-OF-ILLNESS-STUDY FOR GERMANYHanstein, T. J. / Gaiser, G. et al. | 2011
-
PIN33 COST-UTILITY ANALYSIS OF RALTEGRAVIR IN HIV-INFECTED TREATMENT NAïVE PATIENTS IN SWEDENChaudhary, M. / Elbasha, E. H. / Kumar, R. N. / Lundberg, J. et al. | 2011
-
PIN40 DO PATIENTS AND PHYSICIANS HAVE SIMILAR PREFERENCES FOR HEALTH CARE DECISIONS INVOLVING UNCERTAIN OUTCOMES FOR CHRONIC HEPATITIS B IN GERMANY AND TURKEY?Lescrauwaet, B. / Mohamed, A. F. / Johnson, F. R. / Hauber, A. B. et al. | 2011
-
PMS13 OSTEOPOROSIS-RELATED FRACTURE COSTS AMONG FEMALE COMMERCIALLY INSURED AND MEDICARE PATIENTSBonafede, M. / Shi, N. / Viswanathan, H. N. / Yurgin, N. et al. | 2011
-
PMS63 SATISFACTION, PREFERENCE AND REASONS FOR BIOLOGIC TREATMENT DISCONTINUATION IN PATIENTS WITH RHEUMATOID ARTHRITISTandon, N. / Bolge, S. / Annunziata, K. et al. | 2011
-
PRS8 DISEASE PROGRESSION IN CYSTIC FIBROSIS — SYNTHESIS OF SURVIVAL EVIDENCEBecker, C. C. / Vieira, M. C. / Harrow, B. / Liou, T. G. / Jansen, J. P. et al. | 2011
-
PRS23 NON-ADHERENCE IN ISONIAZID TREATED PATIENTS AS MEASURED BY THE TEMPTATION TO SKIP THERAPY (TEST) SCALEDeshpande, C. / Scimeca, S. / Carter, J. / Willey, C. et al. | 2011
-
PRS24 IMPACT OF MORBIDITY, PSYCHOLOGICAL DISTRESS AND LUNG FUNCTION ON PHYSICAL FUNCTIONING IN A RETIRED POPULATIONRoberts, M. / Mapel, D. et al. | 2011
-
PRS30 COMPARISON OF CLINICAL AND PATIENT-REPORTED OUTCOME MEASURES IN CHRONIC OBSTRUCTIVE PULMONARY DISEASEYang, Y. / Pickard, A. S. / Lee, T. et al. | 2011
-
PRM7 DRUG DEVELOPMENT AND PHARMACEUTICAL PRICING IN THE UNITED STATES: THE INFLUENCE OF DRUG INTENDED OUTCOMES OF DRUG PRICINGIaconi, A. / Khalidi, N. / Olanrewaju, O. / Balkrishnan, R. et al. | 2011
-
PRM28 CREATION OF A NEW PSORIASIS QUALITY OF LIFE MEASURE FROM FIVE PREEXISTENT INSTRUMENTS USING RASCH ANALYSIS: THE CALIPSO QUESTIONNAIRESampogna, F. / Styles, I. / Tabolli, S. / Abeni, D. et al. | 2011
-
PRM34 EVALUATING THE SCREENING ABILITY OF PATIENT-REPORTED OUTCOME INSTRUMENTSCoon, C. / McLeod, L. / Arnold, L. / Chandran, A. / Martin, S. et al. | 2011
-
PRM49 TRANSLATION AND LINGUISTIC VALIDATION – METHODOLOGICAL IMPLICATIONS WHEN THE SOURCE MEASURE IS NOT ENGLISHClayson, D. / Verjee-Lorenz, A. / Two, R. / Gerber, R. / Beaudreuil, J. et al. | 2011
-
PCN11 COMPARATIVE EFFECTIVENESS RESEARCH: ERECTILE DYSFUNCTION LONGITUDINAL COSTS ACROSS TREATMENTS FOR PROSTATE CANCERWilson, L. S. / Basu, R. / Paoli, C. / Lian, V. / Wong, A. / Kuo, J. / Sadetsky, N. / Cooperberg, M. / Carroll, P. et al. | 2011
-
PCN13 REAL LIFE OUTCOMES IN 2ND LINE ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC): A PILOT STUDY IN FRANCE AND GERMANY ANALYSING ERLOTINIB VERSUS CHEMOTHERAPYVergnenegre, A. / Heigener, D. F. / Bischoff, H. G. / Chouaid, C. / Taylor-Stokes, G. / Roughley, A. / Walzer, S. et al. | 2011
-
PCN26 BUDGET IMPACT MODEL OF DENOSUMAB FOR SKELETAL RELATED EVENT (SRE) PREVENTION IN PATIENTS WITH BREAST AND PROSTATE CANCERNorthridge, K. / Richhariya, A. / Halperin, M. / Chung, K. / Danese, M. D. et al. | 2011
-
PCN32 COMPARISON OF EPOETIN ALFA AND DARBEPOETIN ALFA DOSING PATTERNS AND COSTS IN CHRONIC KIDNEY DISEASE AND CHEMOTHERAPY-INDUCED ANEMIA OUTPATIENTSLafeuille, M. H. / Bailey, R. A. / Senbetta, M. / McKenzie, R. S. / Lefebvre, P. et al. | 2011
-
PCN33 COST SAVINGS ASSOCIATED WITH TRANSFUSION INDEPENDENCE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME WITH A 5Q- DELETIONBozkaya, D. / Mahmoud, D. / Mitsi, G. / Khan, Z. M. et al. | 2011
-
PCN37 ESTIMATING COST OF TREATMENT IN ELDERLY PATIENTS WITH COLORECTAL CANCER USING MEDICARE DATAKokkotos, F. / Shen, S. / Wang, Z. / Zhang, Y. et al. | 2011
-
PCN71 USING MEASURES OF SOCIETAL VALUE AND ECONOMIC MODELING TO ESTIMATE PRICES FOR CANCER DRUGS IN SOUTH AFRICADranitsaris, G. / Truter, I. / Lubbe, M. / Fourie, S. et al. | 2011
-
PCN76 SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTASES LEAD TO CONSIDERABLE HEALTH RESOURCE UTILISATION IN EUROPE: ANALYSIS OF A MULTINATIONAL OBSERVATIONAL STUDYHechmati, G. / Hoefeler, H. / Bahl, A. / Lü / ftner, D. / Lorusso, V. / Garzó / n Rodriguez, C. / Ashcroft, J. / Suenaert, P. et al. | 2011
-
PCN92 PSYCHOMETRIC COMPARISION OF THE EQ-5D-3L TO THE EQ-5D-5L IN CANCER PATIENTS IN KOREAKim, S. H. / Jo, M. W. et al. | 2011
-
PCN96 CANCER PATIENT PREFERENCES AND WILLINGNESS TO PAY FOR PREVENTING CHEMOTHERAPY INDUCED NAUSEA AND VOMITING IN THE UNITED STATESMiller, P. J. / Balu, S. / Buchner, D. / Walker, M. S. / Stepanski, E. J. / Schwartzberg, L. S. et al. | 2011
-
PCN110 REAL WORLD CLINICAL RESOURCE UTILIZATION OF METASTATIC PROSTATE CANCER PATIENTS IN THE UNITED STATES: RESULTS FROM TWO LARGE CLAIMS DATABASESLafeuille, M. H. / Senbetta, M. / McKenzie, R. S. / Lefebvre, P. et al. | 2011
-
PCN120 WHO CHOSE PRIMARY ANDROGEN DEPRIVATION THERAPY OVER RADICAL PROSTATECTOMY: A RETROSPECTIVE STUDY AMONG VETERANS WITH LOCALIZED PROSTATE CANCERLiu, J. / Shi, L. / Sartor, O. et al. | 2011
-
PGI12 DOSE VARIATIONS WITH ADALIMUMAB AND INFLIXIMAB IN THE TREATMENT OF CROHN'S DISEASE: A CANADIAN ASSESSMENTLachaine, J. / Beauchemin, C. / Goyette, A. / Martel, M. J. et al. | 2011
-
PMH1 IS STIMULANT OR ATOMOXETINE UTILIZATION ASSOCIATED WITH NEUROLOGICAL ADVERSE EVENTS IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD)? A RETROSPECTIVE ANALYSIS OF PROPENSITY SCORE MATCHED DATABhattacharjee, S. / Chen, H. / Bhatara, V. / Aparasu, R. R. et al. | 2011
-
PMH4 RISK OF FALLS AND FRACTURES IN OLDER ADULTS USING ATYPICAL ANTIPSYCHOTICS-A MULTIPLE PROPENSTY SCORE ADJUSTED RETROSPECTIVE COHORT STUDYChatterjee, S. / Chen, H. / Johnson, M. L. / Aparasu, R. R. et al. | 2011
-
PMH16 CHARACTERISTICS OF PATIENTS IN COMMUNITY BEHAVIORAL HEALTH ORGANIZATIONS RECEIVING TWO INJECTABLE FORMS OF ATYPICAL ANTIPSYCHOTIC MEDICATIONS AS COMPARED WITH OTHER ANTIPSYCHOTICSMark, T. / Panish, J. / Mao, L. / Montejano, L. B. / Dirani, R. / Fastenau, J. / Starr, H. L. et al. | 2011
-
PMH25 CLINICAL OUTCOMES AND ECONOMIC COSTS OF SECOND-GENERATION ANTIPSYCHOTICS IN PATIENTS WITH CHRONIC SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDERSBerger, A. / Kushkuley, S. / Sanders, K. / Alvir, J. / Oster, G. et al. | 2011
-
PMH49 CAN THE ILLNESS PERCEPTION QUESTIONNAIRE BE USED TO ASSESS MENTAL HEALTH PRACTITIONERS' PERSPECTIVES ON PATIENTS WITH SCHIZOPHRENIA?Fleming, M. / Martin, C. R. et al. | 2011
-
PMH51 BASELINE RESULTS FROM BEAT THE BLUESPizzi, L. T. / Jutkowitz, E. / Gitlin, L. / Suh, D. C. / Dennis, M. et al. | 2011
-
PMH53 ASSESSING THE IMPACT OF MAJOR DEPRESSIVE DISORDER (MDD) ON FAMILY FUNCTIONING: DEVELOPMENT OF THE DEPRESSION AND FAMILY FUNCTIONING SCALELanç / on, C. / DiBenedetti, D. B. / Lewis, S. / Davis, K. / Danchenko, N. / Franç / ois, C. et al. | 2011
-
PMH58 NEW DISEASE MANAGEMENT PROGRAM FOR OPIOID DEPENDENT PATIENTS DECREASES DRUG USE AND INCREASES 12 STEP MEETING ATTENDANCE: ONE YEAR RESULTS OF A RANDOMIZED CLINICAL TRIALTkacz, J. / Ruetsch, C. et al. | 2011
-
PMH78 PERSISTENCE OF STIMULANT TREATMENT IN CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDERPalli, S. R. / Aparasu, R. R. / Chen, H. / Sherer, J. T. et al. | 2011
-
PMH79 PSYCHOTROPIC POLYPHARMACY IN CHILDREN AND ADOLESCENTS WITH ATTENTION – DEFICIT / HYPERACTIVITY DISORDERPalli, S. R. / Aparasu, R. R. / Chen, H. / Sherer, J. T. et al. | 2011
-
PND23 ECONOMIC EVALUATION OF DEXMEDETOMIDINE FOR SEDATION IN THE INTENSIVE CARE UNITLachaine, J. / Beauchemin, C. et al. | 2011
-
PND25 ECONOMIC TRENDS ASSOCIATED WITH NATALIZUMAB THERAPY IN A COMMERCIALY MANAGED MULTIPLE SCLEROSIS POPULATIONPill, M. / Gilkin, B. et al. | 2011
-
PND36 INTERNAL LOCUS OF CONTROL AND TREATMENT SATISFACTION WITH NATALIZUMABStephenson, J. J. / Kern, D. M. / Agarwal, S. S. / Kamat, S. A. et al. | 2011
-
PND55 USE OF TIME-TO-EVENT ANALYSES TO DEFINE EPISODES OF CARE IN SICKLE CELL DISEASEEworuke, E. / Kauf, T. et al. | 2011
-
PND57 TEMPORAL TRENDS AND GEOGRAPHIC DISCREPANCIES IN PUBLIC EXPENDITURES WITH MULTIPLE SCLEROSIS DRUG TREATMENT IN BRAZILTakemoto, M. M. / Takemoto, M. L. / Fernandes, R. A. / Duarte, G. G. / Tolentino, A. C. / Santos, P. M. / Moretti, A. I. et al. | 2011
-
EE2 VALIDATION OF THE UPDATED CHARLSON COMORBIDITY INDEX (CCI) TO PREDICT HEALTH CARE UTILIZATION FOR DIABETIC PATIENTS USING ADMINISTRATIVE DATACheng, L. I. / Rascati, K. L. / Trice, S. / Lawson, K. / Barner, J. C. et al. | 2011
-
EV4 MORE BANG FOR YOUR BUCK: TAKE A RISK WHEN ANALYSING INTERVIEW DATARoberts, G. et al. | 2011
-
PHP13 THE IMPACT OF A QUALITY IMPROVEMENT INITIATIVE ON INAPPROPRIATE MEDICATION USE IN THE OUTPATIENT ELDERLYDudash, K. / Templin, M. / Keith, S. W. / Del Canale, S. / Maio, V. et al. | 2011
-
PHP20 MEDICATION USE SURVEY OF INPATIENTS WITH BASIC MEDICAL INSURANCE (2010)Xiong, X. et al. | 2011
-
PHP30 CAN PRICING SCHEMES IMPROVE MARKET ACCESS FOR INNOVATIVE HIGH PRICED DRUGS?Anastasaki, E. / Colasante, W. / Imbeah-Ampiah, R. et al. | 2011
-
PHP83 HTA DECISION DRIVERS FOR ACCEPTANCE OF HIGH ICER SUBMISSIONS AND REJECTION OF LOW ICER SUBMISSIONSTernouth, A. M. / Jakel, A. / Plested, M. / Modha, R. et al. | 2011
-
PHP93 AN EXAMINATION OF HOSPITAL-ACQUIRED CONDITIONS BY AGE AND PAYER IN FIFTEEN STATES, 2008Maeda, J. L. / Parlato, J. / Levit, K. / Andrews, R. M. / Jiang, H. J. et al. | 2011
-
PHP96 REASONS FOR REJECTION OF PRO LABEL CLAIMS: AN ANALYSIS BASED ON A REVIEW OF PRO USE AMONG NEW MOLECULAR ENTITIES AND BIOLOGIC LICENSE APPLICATIONS 2006-2010DeMuro, C. / Clark, M. / Mordin, M. / Evans, E. / Copley-Merriman, K. / Fehnel, S. E. / Gnanasakthy, A. et al. | 2011
-
PCV8 EVALUATION OF A SAFETY INITIATIVE AND OUTCOMES FOR PATIENTS ON STATIN-FIBRATE COMBINATION THERAPIES IN THE VETERANS AFFAIRS POPULATIONYi, T. / Tran, J. N. / Bounthavong, M. et al. | 2011
-
PCV16 MANAGING GROWING POPULATION OF TYPE-2 DIABETES FROM COMMUNITY TO TEACHING HOSPITALS IN CHINAZhang, D. / Ji, L. / Hu, D. et al. | 2011
-
PCV24 EVALUATION OF THE CLINICAL FACTORS AND PREVENTIVE MEDICATIONS ASSOCIATED WITH THE LENGTH OF HOSPITAL STAY AMONG ISCHEMIC STROKE PATIENTSAl-Jabi, S. W. / Hassan, Y. / Abd Aziz, N. / Looi, I. / Zyoud, S. H. et al. | 2011
-
PCV34 PROPHYLAXIS USE AND 90-DAY COSTS FOR VENOUS THROMBOEMBOLISM, MAJOR AND MINOR BLEEDING EVENT ANALYSIS IN HOSPITALIZED MEDICALLY ILL PATIENTSBaser, O. / Xie, L. / Yuce, H. / Du, J. / Wang, L. et al. | 2011
-
PCV52 COST-EFFECTIVNESS STUDY OF CITICOLINE IN PATIENTS WITH ACUTE ISCHEMIC STROKE IN RUSSIAVorobyev, P. / Bezmelnitsyna, L. / Borisenko, O. et al. | 2011
-
PCV64 ADHERENCE TO MEDICATIONS WITH ONCE-A-DAY (QD) AND TWICE-A-DAY (BID) DOSING FORMULATIONS IN ACUTE CORONARY SYNDROME (ACS) PATIENTSHess, G. / Bhandary, D. / Fonseca, E. / Kumar, D. / Potter, D. / Smith, D. / Gandhi, S. K. et al. | 2011
-
PSS21 GAP ANALYSIS FOR PATIENT-REPORTED OUTCOMES MEASURES FOR ALOPECIADennee-Sommers, B. / Galipeau, N. / Fitzgerald, K. / Evans, C. / Daniels, S. / Burgess, S. M. et al. | 2011
-
PSY20 ECONOMIC EVALUATION OF SEQUENTIAL ANALGESIC TREATMENT IN THE MANAGEMENT OF MODERATE ANKLE SPRAIN IN MEXICAN ADULTSArreola-Ornelas, H. / Rosado-Buzzo, A. / Garcia-Mollinedo, M. / Muciñ / o-Ortega, E. / Mould-Quevedo, J. F. / Galindo-Suarez, R. M. et al. | 2011
-
PUK5 TREATMENT PATTERNS IN OVERACTIVE BLADDER: REAL-WORLD PATIENT POPULATIONEllsworth, P. / Bavendam, T. / Zou, K. H. / Mastey, V. / Chen, C. I. et al. | 2011
-
PUK11 UPDATED ECONOMIC ANALYSIS OF FESOTERODINE RELATIVE TO TOLTERODINE AND SOLIFENACIN FOR THE TREATMENT OF OVERACTIVE BLADDER: THE SWEDISH PERSPECTIVELee, R. / Snedecor, S. J. / Kvasz, M. G. / Trocio, J. / Borgman, B. et al. | 2011
-
PUK17 UTILIZATION AND ECONOMIC IMPACT OF IV IRON AND ERYTHROPOIESIS STIMULATING AGENTS IN CHRONIC KIDNEY DISEASE PATIENTS: A MULTI-HOSPITAL STUDYJoshi, A. D. / Holdford, D. / Brophy, D. / Harpe, S. E. et al. | 2011
-
PMD10 SCREENING TREATMENT AND CONTROL OF HYPERTENSION IN DIABETIC PATIENTS USING OUTPATIENT VISIT DATASurbhi, S. / Mackey, M. L. et al. | 2011
-
PSU2 USING ELECTRONIC MEDICAL RECORDS TO IDENTIFY POTENTIAL PREDICTORS FOR BARIATRIC SURGERY SUCCESSBenoit, S. / Hunter, T. D. / Steinbuch, M. / Fegelman, E. / Francis, D. / Seeley, R. et al. | 2011
-
PSU18 IMPACT OF HEALTH INSURANCE ON RECEIVING BREAST CONSERVING SURGERY WITH RADIATION IN FLORIDAAli, A. A. / Xiao, H. et al. | 2011
-
PDB5 THE IMPACT OF ANTIDIABETIC-INDUCED HYPOGLYCEMIA ON CLINICAL OUTCOMES AND RESOURCE UTILIZATION AMONG VETERANS WITH TYPE-2 DIABETES MELLITUS (T2DM)Zhao, Y. / Shi, L. / Fonseca, V. / Campbell, C. et al. | 2011
-
PDB16 DIABETES MELLITUS TYPE 2 AND T2DM PLUS HYPERTENSION IN BRAZIL: THE EPIDEMIOLOGIC PROFILE OF THE POPULATION REGISTERED IN THE GOVERNMENT PROGRAM HIPERDIANasciben, V. / Melo, T. G. et al. | 2011
-
PDB20 BUDGET IMPACT ANALYSIS OF THE INTRODUCTION OF SAXAGLIPTIN IN THE TREATMENT OF TYPE-2 DIABETES IN CHILEElgart, J. / Caporale, J. / Aiello, E. C. / Gagliardino, J. J. / Waschbusch, M. / Jotimliansky, L. / Valencia, J. E. et al. | 2011
-
PDB34 PHARMACOECONOMIC EVALUATION OF A PHARMACIST-MANAGED DIABETES CLINICTan, P. S. / Pt, T. et al. | 2011